WO2015068815A1

WO2015068815A1 - Medical assistance system, medical assistance device, medical assistance method, and medical assistance program

Info

Publication number: WO2015068815A1
Application number: PCT/JP2014/079611
Authority: WO
Inventors: 雅弘岩崎
Original assignee: パナソニックヘルスケアホールディングス株式会社
Priority date: 2013-11-08
Filing date: 2014-11-07
Publication date: 2015-05-14

Abstract

　A medical assistance system (100) is provided with a medical device (1) used by a user and a communication device (2) for acquiring usage information of the medical device (1) the communication device (2) being capable of communication with the medical device (1). The communication device (2) has a control unit (26), a display unit (27) controlled by the control unit (26), and a memory (32). The control unit (26) records the usage information of the medical device (1) in the memory (32), assesses the appropriateness of a usage state of the medical device (1) on the basis of the usage information, and causes the display unit (27) to display appropriateness information indicating a level of appropriateness of the usage state, and when the usage state is assessed to be appropriate, the appropriateness information displayed by the display unit (27) is updated to appropriateness information in which the level of appropriateness is raised.

Description

Medical support system, medical support device, medical support method, and medical support program

The present disclosure relates to a medical support device, a medical support system, and the like using a communication device that can communicate with a medical device that is a drug injection device that injects a drug such as insulin or growth hormone.

Conventionally, this type of medical support system has a configuration including a medical device used by a user and a mobile communication device that obtains usage information of the medical device (as similar prior literature, For example, the following patent document 1).

JP 2006-271863 A

In the above conventional example, usage information of the medical device used by the user is transmitted to the mobile communication device. For example, a doctor confirms usage information from the portable communication device and gives medical advice to the user.
In such a system, medical advice is given to the user based on the usage information obtained from the portable communication device by the doctor. However, the advice from the doctor is a so-called command or instruction for the patient, and the continuous use awareness may not be increased.
For example, if the medical device is not used properly and continuously, the advice from the doctor is an expression that condemns it. For this reason, the consciousness that the user himself intends to continue using does not increase.

Therefore, the present disclosure is intended to provide a technology for improving the user's awareness of continuous use of medical devices.

According to one aspect of the present disclosure, a medical support system includes a medical device used by a user and a communication device capable of communicating with the medical device and acquiring usage information of the medical device. The communication device includes a control unit, a display unit controlled by the control unit, and a memory. The control unit records the usage information of the medical device in the memory, determines the appropriateness of the use state of the medical device based on the use information, and displays the appropriateness information indicating the appropriateness level of the use state on the display unit. When it is determined that the use state is appropriate, the appropriateness information displayed on the display unit is updated to appropriateness information with an increased level of appropriateness.
A medical support system according to another aspect of the present disclosure includes a medical device used by a user, a communication device capable of communicating with the medical device and acquiring usage information of the medical device, and a communication device capable of communicating with the communication device. A server for receiving the usage information. The communication device includes a first control unit, a display unit controlled by the first control unit, and a first memory. The server includes a second control unit and a second memory controlled by the second control unit. The first control unit of the communication device records the usage information of the medical device in the first memory, and transmits the usage information to the server. The second control unit of the server records the usage information acquired from the communication device in the second memory, and the first control unit or the second control unit determines the appropriateness of the usage state of the medical device based on the usage information. Determine. The first control unit displays appropriateness information indicating the appropriateness level of the usage state on the display unit of the communication device. When the first control unit or the second control unit determines that the usage state is appropriate, the first control unit increases the appropriateness level by displaying the appropriateness information displayed on the display unit. Update to appropriate relevance information.

The medical support device according to another aspect of the present disclosure acquires use information of a medical device, records the use information of the medical device in a memory, determines appropriateness of the use state of the medical device based on the use information, and uses Appropriate information that indicates the appropriateness level of the state is displayed on the display unit, and when it is determined that the usage state is appropriate, the appropriateness information displayed on the display unit is converted to the appropriateness information that has increased the appropriateness level. To update.
A medical support method according to still another aspect of the present disclosure is a medical support method using a communication device that is communicable with a medical device and acquires usage information of the medical device, and records the usage information of the medical device in a memory. Appropriateness of the use state of the medical device is determined based on the use information, and the appropriateness information indicating the appropriateness level of the use state is displayed on the display unit, and displayed when the use state is determined to be appropriate. Updating the appropriateness information displayed in the section with appropriateness information whose level of appropriateness has been raised.

A medical support program according to still another aspect of the present disclosure is a program that causes a computer to execute the medical support method.

The technology according to the present disclosure is effective for improving the user's awareness of continuous use of medical devices.

The figure which shows schematic structure of the medical assistance system which concerns on Embodiment 1. The perspective view of the medicine injection device The perspective view of the medicine injection device Same as above, sectional view of drug injection device Same as above, control block diagram of drug injection device Same as above, control block diagram of portable communication device Same as above, PC control block diagram The figure which shows the example of a screen of the display part of a portable communication apparatus similarly The figure which shows the example of a screen of the display part of a portable communication apparatus similarly The figure which shows the example of a screen of the display part of a portable communication apparatus similarly The figure which shows the example of a screen of the display part of a portable communication apparatus similarly The figure which shows the example of a screen of the display part of a portable communication apparatus similarly The figure which shows the example of a screen of the display part of a portable communication apparatus similarly The figure which shows the example of a screen of the display part of a portable communication apparatus similarly The figure which shows the example of a screen of the display part of a portable communication apparatus similarly The figure which shows the example of a screen of the display part of a portable communication apparatus similarly The figure which shows the example of a screen of the display part of a portable communication apparatus similarly The figure which shows the example of a screen of the display part of a portable communication apparatus similarly The figure which shows the example of a screen of the display part of a portable communication apparatus similarly The figure which shows the example of a screen of the display part of a portable communication apparatus similarly The figure which shows the example of a screen of the display part of a portable communication apparatus similarly The figure which shows the example of a screen of the display part of a portable communication apparatus similarly The figure which shows the example of a screen of the display part of a portable communication apparatus similarly Same as above, operation flowchart of drug injection device Same as above, operation flowchart of portable communication device Same operation flow chart of drug injection device and portable communication device Same as above, operation flowchart of portable communication device Same operation flow chart of drug injection device and portable communication device Same as above, operation flowchart of portable communication device Same as above, operation flowchart of portable communication device Same as above, operation flowchart of portable communication device Same as above, operation flowchart of portable communication device The figure which shows schematic structure of the medical assistance system which concerns on Embodiment 2. FIG. Same as above, server control block diagram Same as above, operation flowchart of portable communication device and server Same operation flow chart of drug injection device and portable communication device Same as above, operation flowchart of portable communication device and server Same as above, operation flowchart of portable communication device and server Same operation flow chart of drug injection device and portable communication device Same as above, operation flowchart of portable communication device Same as above, operation flowchart of portable communication device Same as above, operation flowchart of portable communication device Same as above, operation flowchart of portable communication device The figure which shows the example of a screen of the display part of the portable communication apparatus which concerns on Embodiment 3. FIG. Same as above, operation flowchart of portable communication device The figure which shows the example of a screen of the display part of the portable communication apparatus which concerns on Embodiment 4. FIG. Same as above, operation flowchart of portable communication device The figure which shows the example of a screen of the display part of a portable communication apparatus similarly Same as above, operation flowchart of portable communication device Same as above, operation flowchart of portable communication device

Hereinafter, embodiments of the present invention will be described in detail with reference to the drawings.
(Embodiment 1)
[1-1 Configuration]
[1-1-1 Configuration of Medical Support System 100]
FIG. 1 shows a medical support system 100 according to an embodiment of the present invention. The medical support system 100 (an example of a medical support system) includes a drug injection device 1 that is an example of a medical device used by a user, and a portable communication device 2 (an example of a communication device) that obtains usage information of the drug injection device 1. And a personal computer 5 held by a doctor who receives usage information of the drug injection device 1 from the portable communication device 2 via the network 3. Communication between the portable communication device 2 and the personal computer 5 is performed using a protocol such as e-mail or Wi-fi. Further, when both are in a short distance, communication may be performed by wireless using NFC, Bluetooth (registered trademark), or wired using a communication cable such as USB.

In the following, the user includes a person who operates the mobile communication device 2 (including a patient (child), a guardian of the patient (parent, etc.), a doctor, etc.).
[1-1-2 Configuration of Drug Injection Device 1]
The drug injection device 1 is, for example, a medical device such as a medical injector. As shown in FIGS. 2 to 3, if the lid 7 of the main body case 6 is opened and the preparation syringe 8 is attached, the drug injection device 1 shown in FIG. It becomes a state. In other words, by pushing the piston 9 into the preparation syringe 8, the preparation can be injected into the human body from the injection needle 10.
In the present embodiment, the preparation stored in the preparation syringe 8 is a chemical solution such as a growth hormone agent that a patient with growth hormone secretion deficiency short stature injects into the human body.
The drug injection device 1 is an operation having an injection switch 12, an OK key 12Aa, a down key 12Ab, and an up key 12Ac in addition to the power switch 11 in order to cause the patient to perform such a growth hormone injection operation. A switch 12A is provided. These power switch 11, injection switch 12, and operation switch 12A are connected to a controller 13 realized by a microprocessor such as a CPU, as shown in FIG.

A drive motor 14 for driving the piston 9 is connected to the control unit 13 via a motor drive circuit 15. Further, a current detection circuit 16 is connected to the motor drive circuit 15, and this current detection circuit 16 is also connected to the control unit 13.
This current detection circuit 16 is used for the drive current of the motor drive circuit 15 that supplies the drive current to the drive motor 14 when the drive motor 14 becomes abnormal or when a large load is applied to the drive motor 14 for some reason. Detect large changes in When the current detection circuit 16 detects an abnormal change in current, the current detection circuit 16 notifies the control unit 13 of the abnormality, and performs an appropriate response by control.
In addition, an encoder 17 is connected to the drive motor 14, and this encoder 17 is also connected to the control unit 13. That is, the operation of the piston 9 is executed by the drive motor 14 while checking the position information of the piston 9 by the encoder 17.

The control unit 13 is also connected to a memory 18 in which an operation program is stored. Further, the control unit 13 is connected to a communication unit 19 that performs near field communication and a memory 20 that stores usage information of the drug injection device 1.
In addition, the code | symbol 21 of FIG. 5 is a battery for performing operation | movement of each part. Reference numeral 22 denotes a display unit that displays an operation method and the like. Reference numeral 23 denotes a needle detection switch that detects attachment of the injection needle 10. Reference numeral 24 denotes a syringe detection switch for detecting the mounting of the preparation syringe 8.
[1-1-3 Configuration of mobile communication device 2]
Next, the mobile communication device 2 shown in FIG. 1 will be described. The mobile communication device 2 is, for example, a communication device such as a smartphone or a mobile communication device, and as shown in FIG. 6, a communication unit 25 (an example of a communication unit) for performing communication with a personal computer or other network or telephone communication. Have The communication unit 25 is connected to a control unit 26 (an example of a medical support device) realized by a microprocessor such as a CPU.

As is well known, such a portable communication device 2 includes a display unit 27, a touch panel 28 (an example of an input unit) displayed in the display unit 27 serving as an operation unit, a power switch 29, a position information detection unit. 30 (GPS in the example of FIG. 6), a sounder 31 for outputting sound, an operation program for executing the operation of each unit, setting data, usage information of the drug injection device 1 and the like 32 (an example of the memory) ), A battery 33 for operating each unit is connected to the control unit 26.
The control unit 26 is connected to an acceleration sensor 34, an illuminance sensor 35, a microphone 36, and a communication unit 37 (NFC IC in the example of FIG. 6) that performs short-range communication.
In this embodiment, what is characteristic is that, as shown in FIG. 6, the control unit 26 of the mobile communication device 2 communicates with the communication unit 19 of the medicine injection device 1 and short-range communication (for example, short-range wireless communication or wired communication) The communication part 37 for performing is connected. That is, the usage information of the medicine injection device 1 is transmitted to the mobile communication device 2 by short-range communication (executed by proximity) between the communication unit 19 and the communication unit 37 of the mobile communication device 2. Yes.

[1-1-4 Configuration of PC 5]
Next, as shown in FIG. 7, the personal computer 5 shown in FIG. 1 is connected to the communication unit 38 that communicates with the communication unit 25 of the mobile communication device 2 via a network or a serial cable, and the communication unit 38. The control unit 39 is realized by a microprocessor such as a CPU, and the memory 40 is connected to the control unit 39.
Further, a display device 41, an operation device 42, and an external storage device 43 are connected to the control unit 39.
Further, the control unit 39 performs short-range communication (executed by proximity or via a serial cable) between the communication unit 19 of the medicine injection device 1 and the short-range communication or the communication unit 37 of the mobile communication device 2. A communication unit 44 (NFC IC in the example of FIG. 7) for performing is connected.

[1-2 Operation]
Hereinafter, the operation of the medical support system 100 according to the present embodiment will be described.
One feature of the present embodiment is displayed on the display unit 27 of the mobile communication device 2 when it is determined that the usage state of the drug injection device 1 is appropriate as in the display examples shown in FIGS. 13 and 14. The appropriate use display (an example of appropriateness information: information indicating the appropriateness level of the use state of the drug injection device) is updated to the plus side (updated to appropriateness information with an increased appropriateness level). To make it a configuration.
The usage state of the drug injection device 1 is evaluated based on the drug use information of the drug injection device 1 and the patient use information related to the drug efficacy of the mobile communication device 2. The drug use information is information related to drug injection (drug use data). For example, whether or not the drug has been administered (injection), the dose (injection) of the drug, the injection (injection) time, etc. Information. Patient use information (also simply referred to as use information) is information related to drug efficacy in drug use information, for example, bedtime, recommended bedtime shown in FIG. 18 described later, bedtime after drug administration, bedtime effective range, One or more drug administration times set for the drug efficacy period and when the patient did not administer the drug before going to bed are added.

The determination that the usage state of the medicine injection device 1 is appropriate means, for example, that the usage state satisfies a predetermined standard. If the use state satisfies a predetermined standard, it is determined that the use state is appropriate. Otherwise, it is determined that the use state is not appropriate.
The appropriate use display of the drug injection device 1 is information indicating the level of appropriateness of the use state of the drug injection device 1 depending on the number of moving images such as numerical values, characters, figures, graphs, symbols, animations, reproduction time, and the like. It means to display. And updating the appropriate use display of the medicine injection device 1 to the plus side (or minus side) means that the display is information (or the level is lowered) that increases the appropriateness level of the use state of the medicine injection device 1. Information) is updated and displayed. For example, when the use of the drug injection device 1 is appropriately performed, the level of appropriateness is increased and updated to a display corresponding to the increased level, and when not, the level of appropriateness is decreased and the level is decreased. Update the display accordingly.

More specifically, as shown in FIG. 13, an unfinished product of the robot is displayed on the display unit 27 as an example of a thing that a user, a child, is pleased with. If the child who is the user injects the growth hormone appropriately for several days (for example, three days), it is updated to the plus side as shown in FIG. 14 (the robot approaches the finished product step by step). It is updated in this way. In the memory 32 of the mobile communication device 2, for example, as understood from FIGS. 13 and 14, the completed robot is stored in a divided state. When the user appropriately injects the medicine (growth hormone agent), the control unit 26 of the mobile communication device 2 determines the use state and updates it to the plus side as shown in FIG. The robot is displayed on the display unit 27 so that the robot approaches the finished product step by step. Therefore, it is possible to improve the awareness of continuously using the drug injection device 1 (an example of a medical device) for the patient and related persons.

In the memory 32 of the mobile communication device 2, illustration data (data for displaying an illustration) of a finished product (for example, a robot) is stored in a state of being divided into a plurality of parts (an example of a plurality of divided parts). Yes. If the medicine injection device 1 is continuously and appropriately used, the display unit 27 of the mobile communication device 2 displays the illustration such as the robot as it is assembled step by step from the divided state.
The illustration data stored in the memory 32 may be data (an example of a plurality of divided portions) for each stage from the part to the finished product. Further, such data concerning the display of the robot may be stored in a dedicated external memory (not shown). As a matter of course, this external memory is connected to the control unit 26. Alternatively, it may be acquired by communication from an external device such as a server.

Hereinafter, the operation of the medical support system 100 will be described in detail.
[1-2-1 Initial operation]
FIG. 25 shows operations of starting and initial setting of a medical support application (an example of a program; hereinafter, also simply referred to as an application) in the mobile communication device 2 according to the present embodiment.
First, the mobile communication device 2 starts up a medical support application installed in advance (S2501). At this time, as shown in the display example of FIG. 8, information indicating the activation of the application is displayed on the display unit 27 of the mobile communication device 2.
Then, the control unit 26 initializes an illustration update flag, a sleeping screen display flag, and a transmission mail flag, and turns them off (S2502).

Next, the control unit 26 determines whether or not the initial setting (setting of user information) for the activated medical support application has been completed (S2503).
When the initial setting is not performed, that is, when the medical support application is activated for the first time, the display as shown in FIG. 9 (user information setting display in the initial setting mode) is performed on the display unit 27 (S2504).
The user (mainly doctor) inputs patient information such as the user ID 49, ID password 74, setting password 72, height, weight, date of birth, etc. of the patient according to the display, and selects the OK key 45 (S2505). ). Note that selecting a key means an operation such as touching a key displayed on the screen.
Next, the control unit 26 of the mobile communication device 2 determines whether or not the device registration setting between the mobile communication device 2 and the medicine injection device 1 has been completed (S2506). Note that this device registration setting is specifically executed by an operation shown in FIG.

If the device registration is not registered, the display unit 27 performs display as shown in FIG. 10 (device setting display in the initial setting mode) (S2507). As shown in FIG. 10, a new registration key 46 for the drug injection device 1, a parent operation key 47 and a child operation key 48 for setting an operation mode, and a mail address input unit 50 are displayed on the display unit 27. If it is determined in S2506 that the device registration setting has been completed, the new registration key 46 in FIG. 10 is displayed as a registration change (S2509). In the initial state, the operation mode is set to the parent mode.
Here, first, a new registration key 46 for device registration is selected (S2508). Then, the operation proceeds to the operation shown in FIG.
FIG. 26 shows a device registration setting operation between the mobile communication device 2 and the medicine injection device 1.

As shown in FIG. 11, the control unit 26 of the mobile communication device 2 performs a display prompting the user to hold the mobile communication device 2 over the medicine injection device 1 (also referred to as an injector) (S2601).
Then, the communication unit 37 (NFC IC or the like) for near field communication of the mobile communication device 2 is activated (S2602).
In this state, if the user holds the portable communication device 2 over the drug injection device 1 (closes it), the communication unit 19 of the drug injection device 1 is activated (S2603).
In the mobile communication device 2, a search command is transmitted from the communication unit 37 to the communication unit 19 of the medicine injection device 1 (S2604).
Then, the communication unit 19 of the medicine injection device 1 receives this search command (S2605), and then the control unit 13 analyzes the command (S2606), and sends a response from the communication unit 19 to the portable communication device 2. It transmits toward the communication part 37 (S2607).

Then, the control unit 26 of the mobile communication device 2 receives the response (S2608), and determines whether or not it is the drug injection device 1 (S2609). If it is determined that the drug injection device 1 is appropriate, a setting data write command is transmitted from the communication unit 37 of the portable communication device 2 to the communication unit 19 of the drug injection device 1 (S2610).
When the communication unit 19 receives this command at the communication unit 19 (S2611), the control unit 13 of the drug injection device 1 analyzes the command (S2612) and stores the setting data in the memory 20 (S2613). Thereafter, a setting completion notification is transmitted from the communication unit 19 to the communication unit 37 of the mobile communication device 2 (S2614).
The control unit 26 of the mobile communication device 2 receives the setting completion notification via the communication unit 37 (S2615), and determines whether the device registration setting is completed (S2616). When the device registration setting is completed, it is further determined whether or not the initial setting is being performed (S2617). If the initial setting is being performed, the process proceeds to S2509 in FIG. 25. If not, the process proceeds to the operation in FIG.

Device registration between the mobile communication device 2 and the medicine injection device 1 is set by the above operation. That is, the mobile communication device 2 enters a state where it is determined that the device has been registered in S2506 of FIG.
In S2506 of FIG. 25, when the control unit 26 of the mobile communication device 2 determines that the device has been registered, the display unit 27 displays a screen displaying the registration change of the new registration key 46 of FIG. 10 as described above. (S2509).
After that, the user selects the parent operation key 47 and the child operation key 48 (selects by touching or pressing down), and after inputting or changing the mail address as necessary (S2510), OK in FIG. When the key 51 is selected (S2511), the initial setting is completed (S2513). It should be noted that the initial setting is not completed even if the OK key 51 is selected after selecting those keys or inputting information without performing device registration (S2512).
When the initial setting is completed, the process proceeds to S2701 in FIG.

After the initial setting (user information setting and device registration setting) is completed, a drug (for example, a growth hormone drug) is injected into the patient using the drug injection device 1.
[1-2-2 Drug injection operation]
FIG. 24 shows a drug injection operation by the drug injection device 1.
When the power switch 11 of the drug injection device 1 is pressed, the control unit 13 starts up a predetermined program and displays an initial screen on the display unit 22 of the drug injection device 1 (S2401).
After displaying the initial screen for 3 seconds, the control unit 13 detects the presence or absence of the preparation syringe 8 by the syringe detection switch 24 that detects the preparation syringe 8 shown in FIG. 4 (S2402).
When the preparation syringe 8 cannot be detected by the syringe detection switch 24, the control unit 13 causes the display unit 22 to display that prompts the user to attach the preparation syringe 8 (S2403).

On the other hand, when the detection of the preparation syringe 8 can be confirmed by the syringe detection switch 24 in S2402, the needle detection switch 23 detects whether or not the injection needle 10 (see FIG. 4) is attached (S2404).
When the mounting of the injection needle 10 cannot be detected, the control unit 13 causes the display unit 22 to display a message prompting the mounting of the injection needle 10 (S2405).
On the other hand, when the detection of the injection needle 10 can be confirmed by the needle detection switch 23 in S2404, the control unit 13 displays a message such as “please blank (bleed out air)” on the display unit 22 (S2406).
In this state, when the injection switch 12 is pressed, the drive motor 14 is driven by the control unit 13, and the piston 9 (see FIG. 4) connected to the drive motor 14 is slightly moved in the distal direction (injection needle). To the side). As a result, a blanking (air bleeding) operation is performed, and a display such as “during blanking (air bleeding)” is displayed on the display unit 22 (S2407).

Further, the information that the blanking (air venting) operation has been executed is recorded by the control unit 13 in the memory 20 connected to the communication unit 19 (S2408).
Next, the control unit 13 causes the display unit 22 to display “Injection is possible” or the like (S2409). In this state, the user inserts the injection needle 10 into the human body, and presses the injection switch 12 of the medicine injection device 1 in this state. As a result, the control unit 13 drives the drive motor 14 to move the piston 9 toward the injection needle 10. Thereby, the medicine such as the growth hormone agent in the preparation syringe 8 is injected into the human body. At this time, the fact that an injection is in progress is displayed to the user by displaying “injection” or the like on the display unit 22 (S2410).
When the injection of the drug such as the growth hormone agent is completed, the control unit 13 injects the drug use data (the drug injection operation, the amount of the injected drug (injection amount), the time of injection, etc.). Information) is recorded in the memory 20 connected to the communication unit 19 (S2411 and S2412). Here, the medicine use data can also be recorded in the memory 18 of the medicine injection device 1.

Next, the control unit 13 displays such as “injection is completed” on the display unit 22 (S2413). Thereby, the user knows completion of the medicine injection. Thereafter, the user removes the injection needle 10 from the human body and presses the power switch 11 again. Thereby, operation which interrupts | blocks the power supply of the chemical | medical agent injection apparatus 1 is performed. As a result, the control unit 13 causes the display unit 22 to display “See You” or the like, and the operation of the pharmaceutical injection device 1 ends (S2414).
As described above, when the medicine injection is completed, the medicine use data (information on the medicine injection operation and information on the injected medicine, etc.) is recorded in the memory 20 connected to the communication unit 19 of the medicine injection device 1. This medicine use data is transmitted to the mobile communication device 2 as will be described later, and is also transmitted to the personal computer 5 via the mobile communication device 2, the network 3, and the near field communication. At the time of this transmission (operation of FIG. 28), the mobile communication device 2 needs to activate a medical support application.

The drug injection device 1, the portable communication device 2, and the personal computer 5 include the

communication units

19, 37, and 44 that perform short-range communication, so that the short distance from the drug injection device 1 to the portable communication device 2 or the personal computer 5 Communication is also possible.
Of course, near field communication can also be performed between the mobile communication device 2 and the personal computer 5. Further, when the short-range communication from the medicine injection device 1 to the portable communication device 2 or the personal computer 5 or from the portable communication device 2 to the personal computer 5 fails, the display unit is similar to the display as shown in FIG. An error message is displayed at 27.
[1-2-3 Data acquisition / update indicating usage status]
FIG. 27 shows data acquisition and determination operations that indicate the use state of the pharmaceutical injection device 1 that is mainly executed by the control unit 26 of the mobile communication device 2 in accordance with the medical application program. It is assumed that the control unit 26 of the mobile communication device 2 has completed the above-described series of initial operations (S2502 to S2513 in FIG. 25 and S2601 to S2617 in FIG. 26). The following description is based on the assumption that the operation is shifted to the operation of FIG.

First, the control unit 26 of the mobile communication device 2 determines ON / OFF of the illustration update flag (S2701). This illustration update flag is initialized (OFF) in S2502 of FIG. 25 when the application is activated. Therefore, immediately after the application is activated, the illustration update flag is determined to be OFF, and the process proceeds to S2711. If the illustration update flag is determined to be ON, the process proceeds to S2702, which will be described later.
If it is determined that the illustration update flag is OFF, it is determined whether the bedtime screen display flag is ON or OFF (S2711). The sleeping screen display flag is also initialized (OFF) when the application is activated. Therefore, immediately after the application is started, the bedtime screen display flag is determined to be OFF, and the process proceeds to S2712. On the other hand, if it is determined that the sleeping screen display flag is ON, the operation proceeds to the operation shown in FIG.

When it is determined that the sleeping screen display flag is OFF, a different screen is displayed on the display unit 27 according to the set operation mode. That is, the operation mode is set through operation of an operation key displayed on the screen as shown in FIG.
In S2712, the control unit 26 selects a screen to be displayed on the display unit 27. For example, if the child mode is selected and set, a main screen for children is displayed on the display unit 27 as shown in FIG. 13 (S2713). However, in the case of the first administration, the robot illustration in FIG. 13 is not displayed. When the parent / doctor mode is set, a main main screen as shown in FIG. 15 is displayed on the display unit 27 (S2716). 15 and 16 are parent screens corresponding to the child screens of FIGS. 13 and 14 when the operation mode is set to the parent mode.

In any of these cases, when the user selects the data acquisition key 52 (FIG. 13, FIG. 15) displayed on the display unit 27 (S2714, S2717), the display unit 27 displays the mobile communication as shown in FIG. A display that prompts the device 2 and the medicine injection device 1 to come close to each other is displayed. And the portable communication apparatus 2 transfers to the acquisition operation | movement of the chemical | medical agent use data shown in FIG. 28 mentioned later.
Further, when the control unit 26 detects that the sleep (sleeping) key (reference numeral 69 in FIGS. 13, 15, and 16) is selected (S <b> 2715 and S <b> 2718), acquisition of bedtime information in FIG. 30 described later is acquired. Move to operation.
Further, when the control unit 26 detects that the setting key 73 (FIGS. 15 and 16) has been selected when the operation mode is set to the parent mode (S2719), the setting data in FIG. Move to input operation.

In the following, each operation for obtaining / updating usage data will be described.
(1. Acquisition of drug use data)
28, after the user selects the data acquisition key 52 (FIGS. 13 and 15) displayed on the display unit 27 of the mobile communication device 2 (S2714 and S2717 in FIG. 27), the drug use data from the drug injection device 1 is displayed. The operation for acquiring is shown.
On the screen of the display unit 27, as shown in FIG. 11, a display for prompting the mobile communication device 2 and the medicine injection device 1 (also referred to as an injector) to approach each other is made (S2801).
The communication unit 37 (NFC IC in the example of FIG. 6) for short-range communication of the mobile communication device 2 is activated (S2802). In this state, if the user holds the mobile communication device 2 over the drug injection device 1, the drug The communication unit 19 of the injection device 1 is activated (S2803).

In the mobile communication device 2, a search command is transmitted from the communication unit 37 to the communication unit 19 of the medicine injection device 1 (S2804). Then, the communication unit 19 of the drug injection device 1 receives this search command (S2805), and subsequently analyzes the command by the control unit 13 of the drug injection device 1 (S2806) and sends a response from the communication unit 19 It transmits toward the communication part 37 of the portable communication apparatus 2 (S2807).
Then, the control unit 26 of the mobile communication device 2 receives the response via the communication unit 37 (S2808), determines whether or not it is the drug injection device 1 (S2809), and an appropriate drug injection device. If it is 1, the medicine use data read command is transmitted from the communication unit 37 of the portable communication device 2 to the communication unit 19 of the medicine injection device 1 (S2810).
When the communication unit 19 receives this command at the communication unit 19 (S2811), the control unit 13 of the drug injection device 1 analyzes the command (S2812) and acquires drug use data from the memory 20 (S2813). Thereafter, the medicine use data is transmitted from the communication unit 19 to the communication unit 37 of the mobile communication device 2 (S2814).

The drug use data refers to information related to drug injection (drug use data). For example, whether or not the drug has been administered (injection), the dose (injection) of the drug, the administration (injection) time, etc. Means information and included in the patient use information described above. Further, when this medicine use data is stored in the memory 18 of the medicine injection device 1, the medicine use data is acquired from the memory 18.
The communication unit 37 of the mobile communication device 2 receives the drug use data including the drug injection record recorded in the memory 20 or the like of the drug injection device 1 by the short-range communication between the communication units 19 and 37 (S2815).
Next, the control unit 26 of the mobile communication device 2 determines whether the received medicine use data is unreceived (that is, medicine use data received for the first time) (S2816).

If new drug use data has been received, the process proceeds to S2817; otherwise, the process proceeds to S2820.
When new drug use data is received, a process (patient use information construction process) for constructing display data as shown in FIGS. 13 and 15 is performed (S2817) and stored in the memory 32 (S2818). .
Next, the control unit 26 sets the mail transmission flag to ON (S2819). As described above, the mail transmission flag is initialized (OFF) after the application is started. Therefore, here, the mail transmission flag is set to ON.
Thereafter, the process proceeds again to S2810 to S2816. In S2816, the control unit 26 determines that the data is not unreceived data (that is, already received data), and proceeds to S2820.

In S2820, the presence / absence of a mail transmission flag is determined (S2820). In S2819, since the mail transmission flag is set to ON, as shown in FIG. 22, the display unit 27 displays whether or not to transmit mail to the personal computer 5 (S2821). As shown in FIG. 22, since the mail transmission key 53 and the cancel key 54 are displayed on the display unit 27, in the next S2822, operations based on these key operations are executed.
That is, when the mail transmission key 53 (“Yes” key in the example of FIG. 22) 53 is selected, an operation of transmitting the patient use information in the memory 32 to the mail address set in FIG. 10 is executed (S2823). At this time, as shown in FIG. 23, the display unit 27 displays a screen during mail transmission.
As for the contents of the mail transmitted at this time, patient use information (information related to drug injection, information related to sleeping, etc.) is described in the text or attached as a data file. The personal computer 5 receives this mail and acquires patient use information. In addition, the personal computer 5 can obtain it by short-range communication (NFC, Bluetooth (registered trademark), USB communication cable connection, etc.) between the communication unit 19 of the pharmaceutical injection device 1 and the communication unit 44 of the personal computer 5 without sending an email. You can also. Further, the personal computer 5 may acquire the use information by using file browsing software.

If the cancel key (“No” key in the example of FIG. 22) 54 is selected in S2822, the process proceeds to S2901 in FIG. 29 without sending mail to the personal computer 5.
Subsequently, the mobile communication device 2 proceeds to the drug administration time data generation / update operation shown in FIG. This will be described later.
(2. Acquisition of bedtime information)
In FIG. 27, the control unit 26 of the mobile communication device 2 detects that the sleep (sleeping) key (reference numeral 69 in FIGS. 13, 15, and 16) is selected (S2715 and S2718). Move to operation.
FIG. 30 shows an operation for acquiring the actual bedtime information of the patient. In S3001, since the bedtime key 69 is displayed on both the main screen for children of FIG. 13 and the main screen for parent of FIG. 15, this bedtime key 69 is selected after drug administration.

Then, the control unit 26 acquires date and time information of the time when the bedtime key 69 is pressed (S3001), and performs patient use information construction processing (S3002). That is, in S3002, patient usage information is constructed from the drug usage data (including the time of injection) and the bedtime, and is stored in the memory 32 of the mobile communication device 2 (S3003).
Next, the illustration update flag is set to ON (S3004), and the sleeping screen display flag is set to ON (S3005).
Subsequently, the mobile communication device 2 proceeds to the drug administration time data generation / update operation shown in FIG. This will be described later.
(3. Setting data input)
FIG. 31 shows each setting data after the user (mainly a doctor) selects the setting key 73 (FIGS. 15 and 16) displayed on the display unit 27 (parent / doctor setting screen) of the mobile communication device 2. The operation to input is shown. When the control unit 26 of the mobile communication device 2 detects that the setting key 73 is selected (S2719 in FIG. 27), for example, the screen shown in FIG. 18 is displayed on the display unit 27 (S3101).

This setting screen includes an alarm valid key 55 (“On” key in the example of FIG. 18), an alarm invalid key 56 (“Off” key in the example of FIG. 18), and a recommended bedtime setting unit for setting the administration alarm. 57, bedtime interval setting unit 58 after administration (infusion), bedtime effective range setting unit 59, morning administration setting unit 60, drug efficacy period setting unit 61, achievement degree increase / decrease (achievement degree increase / decrease point in the example of FIG. 18) setting part 62, an illustration update setting unit 63, an illustration evolution setting unit 64, an automatic end setting unit 65, a save key 66 for saving these setting information, and the like are displayed. Each setting data is set by the user (mainly a doctor) selecting or inputting data via this setting screen. It should be noted that the recommended bedtime setting unit 57, the bedtime interval setting unit 58 after administration (infusion), the bedtime effective range setting unit 59, the morning administration setting unit 60, the drug efficacy period setting unit 61, the achievement rate increase / decrease (in the example of FIG. When the parent sets the achievement level increase / decrease point) setting unit 62, the illustration update setting unit 63, and the illustration evolution setting unit 64, it may be set by inputting a setting password.

The alarm valid key 55 is for causing the display unit 27 to display such as shown in FIG. 17 at the scheduled administration (injection) time, and the alarm invalid key 56 is for canceling it. belongs to. By selecting any key, the administration alarm is set to be valid / invalid (S3102). The notification of the alarm may be a display on the display unit 27 (for example, LED lighting / flashing, display on the screen with characters, graphics, or the like), or may be performed by sound or vibration.
When the set alarm time is reached, a display informing the drug administration is made on the display unit 27 (see FIG. 17), and the alarm is ended when the end key 71 is pressed. At this time, if the “snooze” key 79 is pressed, the alarm is temporarily stopped, and after a predetermined time, the “administration alarm” is activated again.

The recommended bedtime setting unit 57 is a part for setting a recommended bedtime for each age, and performs a recommended bedtime setting (S3103).
Next, the post-administration sleep interval setting unit 58 sets an interval until bedtime after drug administration (drug injection) and depends on the efficacy of the drug, and is set here (S3104).
The next bed effective range setting unit 59 sets the achievement level addition condition (for example, bed time−drug administration time ≦ sleep interval after drug administration ± sleep effective range), and the setting is performed here (S3105). ). For example, if the drug administration time is 1.5 hours before bedtime, and the bedtime interval after drug administration is 1 hour and the bedtime effective range is within +/− 30 minutes, bedtime-drug administration time = 1.5 hours, so the achievement degree addition condition is satisfied.
Next, the morning administration setting unit 60 sets the morning administration time (for example, 7:00 am) on the next day when the drug administration is forgotten, and the setting is performed here (S3106).

The drug efficacy period setting unit 61 sets the time during which the administered drug works effectively in the body, where setting is performed (S3107).
The achievement level increase / decrease setting unit 62 is a part for increasing the points when the bedtime is within the valid range (for example, 30 minutes, etc.). Here, the setting is performed (S3108). For example, the illustration displayed on the display unit 27 is updated based on the increase in the number of points.
Next, the illustration update setting unit 63 sets the frequency (number of days, etc.) of updating the illustration on the display unit when achievement level increase / decrease points are continuously added, and the setting is performed here. (S3109). That is, as shown in FIG. 13, for example, an illustration of a robot is displayed on the display unit 27, and if an appropriate medicine is administered continuously for a predetermined period (for example, continuously for 3 days), the illustration is displayed in FIG. 14. In this way, it is updated. Of course, the illustrations in the main main screen display of FIGS. 15 and 16 are also updated.

Next, the illustration evolution setting unit 64 is for setting the frequency (number of days etc.) at which the illustration of the robot shown in FIG. 14 is changed, and the setting is performed here (S3110). In this example, if appropriate drug administration is executed continuously for one month, illustration data of a new robot (for example, a new robot that has evolved) is acquired, and the illustration displayed on the display unit 27 is changed. ing.
Next, the automatic termination setting unit 65 is for setting a time for automatically terminating this application at bedtime, and the setting is performed here (S3111).
If the save key 66 is selected after setting these setting data (S3112), the setting information shown in FIG. 18 is saved in the memory 32 of the mobile communication device 2 (S3113).
Although not particularly illustrated, after the save key 66 of FIG. 18 is selected, the control unit 26 causes the display unit 27 to display the screen of FIG. 20 for the doctor, and for the parent, The screen of FIG. 19 is displayed. FIG. 20 shows patient physical information (height, weight, date of birth, etc.), device registration, operation mode setting, user ID, ID password, which are initially set by the doctor in FIG. 9 and FIG. It is a screen for making it possible to set a setting password, a dosage, and the like. FIG. 19 shows the conditions of the patient's physical information (height, weight, date of birth, etc.), user ID, etc., initially set by the parent in FIGS. 9 and 10, and device registration, operation mode setting, mail address This is a screen for changing settings such as. Note that it is possible to change the setting of the physical information by inputting a setting password. When the settings in FIGS. 19 and 20 are completed, the save key 68 is selected, and the updated setting information is saved in the memory 32 of the mobile communication device 2.

Subsequently, the mobile communication device 2 proceeds to the drug administration time data generation / update operation shown in FIG.
(4. Display screen)
Settings on the screens of FIGS. 9, 10, and 20 are mainly performed by a doctor, and setting data input on the screen of FIG. 18 is performed by a doctor or a parent under the guidance of a doctor. The initial setting on the screen of FIG. 19 is performed by the parent.
That is, the settings on the screens of FIGS. 9 and 18 are initially performed by the doctor. Also, in the setting on the screen of FIG. 20, the doctor sets the user ID, ID password, setting password, dosage, etc. using the personal computer 5 in order to confirm the situation.
9 and 10 can be set only for the first time when the application is started. After selecting the OK keys 45 and 51 in FIGS. 9 and 10, these FIGS. 9 and 10 are not displayed. If resetting is required, the initial operation on the screens of FIGS. 9 and 10 is performed by reinstalling the application again.

Then, after the doctor completes the initial settings as described above and selects the setting key 73 on the parent screen (S2719 in FIG. 27), the settings shown in FIGS. 18 and 20 are completed (FIG. 20). When the child operation key 48 is selected, these screens are not displayed. When the parent operation key 47 shown in FIG. 20 is selected, the settings shown in FIGS. 10, 18 and 19 are executed by the parent thereafter. Note that these screens may not be displayed if the settings in FIGS. 18 and 19 are completed.
That is, FIGS. 10 and 19 are mainly set by the parent. After selecting the parent operation key 47 of FIG. 19, the parent inputs the child's height, weight, date of birth, etc., and the save key 67 Select. Thereafter, the child operation key 48 is selected after the setting of the parent so that the child can check the screens of FIGS.

The screen shown in FIG. 18 may be displayed by inputting a setting password after selecting the setting key 73 (FIGS. 15 and 16).
(5. Generation / update of drug administration time data)
FIG. 29 shows the data generation / update operation of the drug administration time.
The control unit 26 of the mobile communication device 2 determines whether or not there is a drug administration today from the drug use data received in S2815 of FIG. 28 (S2901). If there is drug administration today, the process proceeds to S2902, and if not, the process proceeds to S2909.
The control unit 26 determines whether or not the drug injection has been executed before the recommended time of drug injection saved by the input of the setting data (here, bedtime-sleep interval after administration) (S2902). That is, according to the setting on the screen of FIG. 18, if the bedtime is 21:00 (9 pm), it is set so that the normal drug administration is performed at 20:00 (8 pm) one hour before that. However, in this S2902, it is determined whether the administration time is before or after 8:00 pm. Therefore, if today's administration time is after 8:00 pm, the process proceeds to S2903, and the next administration time is stored in the memory 32 as 8:00 pm (20:00) which is the normal administration time of tomorrow (S2906). ).

On the other hand, when the medicine administration time is, for example, 6:00 pm, the process proceeds from S2902 to S2904. In S2904, it is determined whether or not the administration time is within the drug efficacy period (in this example, 4 hours) minus 2 hours with respect to the normal drug administration time. For example, if the administration time is 6 pm, this condition is satisfied, and the process proceeds to S2903.
On the other hand, if the drug administration time is, for example, 3:00 pm, the condition is not satisfied in S2904. Therefore, in S2905, the next medicine administration time is reset at 8:00 pm today, and stored in the memory 32 in S2906. That is, if the drug (growth hormone drug) of this embodiment is not administered for 4 hours before going to bed, the efficacy of the drug will not be exerted. It is urged to administer the drug at 8 o'clock.

After S2906, the process proceeds to S2907 and S2908. That is, in S2907, it is determined whether the alarm setting is set. If the alarm setting shown in FIG. 18 is set, the alarm time is set in S2908. For example, in the case of administration at 3 pm as described above, an alarm is set so that an alarm sounds again at 8 pm in order to prompt the administration of the medicine again at 8 pm on that day.
On the other hand, if it is determined in S2901 that the last drug administration time is before the previous day (when there is drug administration by the previous day), the process proceeds to S2909. In that case, the control unit 26 determines whether or not drug administration is performed on the previous day (S2909). If there is no drug administration on the previous day, next time, the drug administration time is set tomorrow morning. (S2910). On the other hand, if the drug administration on the previous day is performed, the control unit 26 sets the next administration time to the normal time of tomorrow (for example, the drug administration time at 8:00 pm) (S2911), proceeds to S2906 to S2908, The memory for the next administration time and alarm setting are performed in the same manner as described above.

After the alarm setting or the like is performed as described above, the operation of the control unit 26 of the mobile communication device 2 proceeds to S2701 in FIG.
[1-2-4 Operational status judgment]
(1. Update and display of illustration data)
The mobile communication device 2 determines whether the illustration update flag is present (ON / OFF) (S2701).
In the present embodiment, when the drug is continuously administered by the illustration update setting unit 63 of FIG. 18 for a set period (for example, three days), the illustration is updated. In S2701, when the control unit 26 determines that the illustration update flag is set to ON, the process proceeds to S2702. On the other hand, for example, if today is the first drug administration, since the illustration update flag is OFF in S2701, the process proceeds to S2711 as described above.

In S2702, the control unit 26 determines whether or not the actual drug administration time is within +/− 30 minutes (sleeping effective range setting unit 59 in FIG. 18) of the bedtime. In S2702, if the medicine administration time is within the set time, the process proceeds to S2703 and achievement points are increased. Then, it is determined whether or not this is a point up for three consecutive days (FIG. 18) (S2704). If there is a point up for three consecutive days, the illustration is updated (S2705). That is, the robot illustration 75 shown in FIG. 13 is updated to a finished product as shown in the illustration 76 shown in FIG.
On the other hand, if the actual drug administration time is outside the set range in S2702, the control unit 26 performs point-down in S2706, and retracts the illustration in S2707. That is, the robot illustration 76 shown in FIG. 14 is changed to the original state as shown in the illustration 75 of FIG.

Further, as a result of repeating S2705, for example, when it is determined that point-up for one month has been achieved (S2708), the control unit 26 changes the illustration to a new robot (S2709). In this state, the control unit 26 clears (OFF) the illustration update flag in S2710. Thus, a new illustration (for example, an evolved robot) is displayed on the screen display for children in FIGS.
Of course, the illustrations in the main main screen display of FIGS. 15 and 16 are also updated or changed.
Subsequently, in S2711, when the control unit 26 determines that the sleeping screen display flag is ON, the control unit 26 proceeds from S2711 in FIG. 27 to S3201 in FIG. The bedtime display flag is set to ON when the bedtime key 69 is selected in FIG. 13 or 15 (S2715, S2718) and bedtime information is acquired (S3005 in FIG. 30).

If it is determined in S2711 that the sleeping screen display flag is OFF, the process proceeds to S2712 and the process described above. If it repeats, if child mode is selected in S2712, the display as shown in FIG. 13 will be made on the display part 27 (S2713), and if the parent mode is selected, it will be shown in FIG. Such a display is made (S2716).
When this S2713 (child screen) is displayed, the control unit 26 detects that the injection data acquisition key 52 shown in FIG. 13 has been selected (S2714), as described above, S2801 in FIG. Migrate to If it is detected that the good night key 69 (FIG. 13) is selected (S2715), the process proceeds to S3001 in FIG. 30 as described above.
On the other hand, when S2716 (parent / doctor screen) is displayed, if it is detected that the injection data acquisition key 52 shown in FIG. 15 is selected (S2717), as described above, S2801 in FIG. Migrate to If it is detected that the sleep key 69 (FIGS. 15 and 16) is selected (S2718), the process proceeds to S3001 in FIG. 30 as described above. Furthermore, when it is detected that the setting key 73 has been selected (S2719), the process proceeds to S3101 in FIG. 31 as described above.

(2. Achievement evaluation display)
As described above, when it is determined in S2711 of FIG. 27 that the sleeping screen display flag is ON, the process proceeds to S3201 of FIG.
FIG. 32 shows an operation of generating and displaying display data corresponding to the degree of continuous achievement of the proper use state of the pharmaceutical injection device 1.
In S3201 of FIG. 32, the control unit 26 determines an increasing tendency of the achievement level. First, when drug administration is appropriately performed for three consecutive days, the control unit 26 sets the display unit 27 to display a compliment (a word to encourage) as shown in FIG. 14 in S3202. In addition, when the drug administration has been appropriately performed for only two days, the control unit 26 sets the display unit 27 to display a word (advice) for prompting continuous execution in S3203. On the contrary, the control unit 26 is configured to display on the display unit 27 a word that prompts the drug administration to be performed continuously (administration instruction) when appropriate drug administration is not continuously performed. (S3204). These display data may be stored in advance in a plurality of memories and output according to conditions.

Then, after these processes of S3202, S3203, and S3204, the control unit 26 clears the sleeping screen display flag (S3205). Then, the above-described advice message is displayed on the display unit 27 as shown in FIG. 14, for example (S3206).
Thereafter, when it is determined that the no-operation time has elapsed for a predetermined time (1 minute in the example of FIG. 43) or more (S3207), the control unit 26 ends the display on the display unit 27 and ends the application.
During this time, when the end key 70 in FIG. 14 is operated (S3208), the display on the display unit 27 is ended at that time, and the application is ended.
[1-3 Effects, etc.]
As described above, in the present embodiment, the control unit 26 of the mobile communication device 2 communicates with the communication unit 19 of the drug injection device 1 through the communication unit 37, and the usage state of the drug injection device 1 is stored in the memory 32. In addition to recording, when it is determined by the control unit 26 of the mobile communication device 2 that the use state of the drug injection device 1 is appropriate, the medicine injection device 1 displayed on the display unit 27 of the mobile communication device 2 Update the appropriate usage indication to the plus side.

For this reason, if the medicine injection device 1 is appropriately used, the appropriate use display of the medicine injection device 1 displayed on the display unit 27 of the mobile communication device 2 is updated to the plus side. 1 can be easily grasped, and the user's awareness of continuous use of the pharmaceutical injection device 1 can be improved.
[1-4 Modification]
[1-4-1 Modification 1]
As a modification of the above-described first embodiment, the bedtime is set by operating the operation switch 12A of the medicine injection device 1 without using the mobile communication device 2, and the bedtime is set in the memory 18 of the medicine injection device 1. It can also be realized by managing time and updating the illustration.
In this case, the illustration information is stored in advance in the memory 18 of the medicine injection device 1.

[1-4-2 Modification 2]
Further, as another variation, as a determination as to whether or not a medical device such as a drug injection device is continuously being used appropriately, drug use data indicating whether or not the drug has been administered (injection) (related to drug injection) Information: For example, it is not determined based only on the dose, time of administration, etc. of the drug, but is related to the drug to be administered (injected) and is different from the drug use data (user life information: (E.g., a combination of a plurality of information including sleep time, amount of activity in normal life, amount of exercise, meal time, or bedtime), and continuously appropriate based on drug use data and user life information, etc. By determining whether or not the user is using the product, it is possible to update an illustration for raising the consciousness of the user himself / herself to continue the use or to give a medication instruction.

Moreover, it is also possible to display a list of the history of such medicine use data and user life information, etc., so that not only the patient but also the parent or the like may accurately grasp the use status.
(Embodiment 2)
Next, the second embodiment will be described below. In addition, about the structure or function similar to Embodiment 1, the same code | symbol is attached | subjected and description is abbreviate | omitted.
[2-1 Configuration]
[2-1-1 Configuration of Medical Support System 200]
FIG. 33 shows a medical support system 200 according to Embodiment 2, which is another embodiment of the present invention. The medical support system 200, a drug injection device 1 that is an example of a medical device used by a user, a portable communication device 2 that obtains usage information of the drug injection device 1, and the portable communication device 2, A server 4 for receiving usage information via the network 3 and a personal computer 5 held by a doctor are provided.

The second embodiment is different from the first embodiment described above in that the server 4 is connected by a network. Therefore, since the medicine injection device 1, the portable communication device 2, and the personal computer 5 are the same as those in the first embodiment, the configuration / structure (see FIGS. 2 to 7) regarding these common devices and the medicine injection device 1 Description of the injection operation (flowchart in FIG. 24) and the like is omitted to avoid complication. However, since the configuration and the operational effects are exactly the same, the description of Embodiment 1 is incorporated as necessary.
[2-1-2 Configuration of mobile communication device 2]
Next, mobile communication device 2 shown in FIG. 33 has server 4 and other network or communication unit 25 for making a telephone call, as in the configuration shown in FIG. 6 of the first embodiment. The unit 25 is connected to the control unit 26 (an example of a first control unit).

Such a portable communication device 2 includes a display unit 27, a touch panel 28 displayed in the display unit 27 serving as an operation unit, a power switch 29, a position information detection unit 30 (GPS in the example of FIG. 6), and an audio output. A sounder 31 to be performed, a memory 32 (an example of a first memory) storing an operation program for executing the operation of each unit, setting data, usage information of the drug injection device 1, and the like, and a battery for performing the operation of each unit 33 is connected to the control unit 26.
The control unit 26 is connected with an acceleration sensor 34, an illuminance sensor 35, a microphone 36, and a communication unit 37 (NFC IC in the example of FIG. 6; an example of a first communication unit) that performs short-range communication. Yes.
In the present second embodiment, what is characteristic is a communication unit 37 for performing short-range communication with the communication unit 19 of the pharmaceutical injection device 1 in the control unit 26 of the portable communication device 2, as shown in FIG. 6. As shown in FIG. 33 and the configuration shown in FIG. 33, the communication unit 25 (one example of the communication unit or one example of the second communication unit) that performs network connection with the server 4 is also connected to the control unit 26. It has been done.

That is, the drug use information of the drug injection device 1 is transmitted to the mobile communication device 2 by short-range communication (executed by proximity) between the communication unit 19 and the communication unit 37 of the mobile communication device 2, and then Patient use information is constructed, and this patient use information is transmitted to the server 4 via the communication unit 25.
[2-1-3 Configuration of server 4]
Next, as shown in FIG. 34, the server 4 shown in FIG. 33 includes a communication unit 81 that performs communication with the communication unit 25 of the mobile communication device 2, communication with the communication unit 38 of the personal computer 5, and the communication unit 81. And a control unit 82 realized by a microprocessor such as a CPU, and a memory 83 connected to the control unit 82. In addition, a display device 84, an operation device 85, and an external storage device 86 are connected to the control unit 82.

[2-2 Operation]
The following operation in the second embodiment is performed using the display on the display unit 27 of the mobile communication device 2 as described in the first embodiment. In the second embodiment, since the display contents shown in FIGS. 8 to 21 are common, a part of the description of the display of the common parts is omitted.
The feature of the second embodiment is displayed on the display unit 27 of the mobile communication device 2 when it is determined that the usage state of the drug injection device 1 is appropriate as in the display examples of FIGS. 13 and 14. Appropriate use display (an example of appropriateness information: information indicating the appropriateness level of the use state of the drug injecting device) of the drug injecting apparatus 1 is updated to the plus side (updated to appropriate information with an increased appropriateness level) )

More specifically, as shown in FIG. 13, an unfinished product of the robot is displayed as one example of what the child who is the user is pleased with. If the child who is the user injects the growth hormone appropriately for several days (for example, three days), it is updated to the plus side as shown in FIG. 14 (the robot approaches the finished product step by step). Is updated).
In the memory 83 of the server 4, for example, as understood from FIGS. 13 and 14, the completed robot is stored in a divided state. If the user appropriately injects the medicine (growth hormone agent), the control unit 82 of the server 4 receives the usage information from the communication unit 25 of the mobile communication device 2 via the communication unit 81. Based on the usage information, the control unit 82 transmits the illustration information in the memory 83 to the mobile communication device 2 via the communication unit 81. As a result, the control unit 26 of the mobile communication device 2 determines the usage state and updates it to the plus side as shown in FIG. 14 (assembles in stages) so that the robot approaches the finished product in stages. It is displayed on the display unit 27. Details will be described later.

Therefore, it is possible to improve the consciousness of continuing to use the pharmaceutical injection device 1 (an example of a medical device) for the patient and related persons.
In the memory 83 of the server 4, illustration data (data for displaying an illustration) of a finished product (for example, a robot) is stored in a state of being divided into a plurality of parts (an example of a plurality of divided parts). Yes. If the medicine injection device 1 is continuously and appropriately used, the display unit 27 of the mobile communication device 2 displays the illustration such as the robot as it is assembled step by step from the divided state.
The illustration data stored in the memory 83 may be data (an example of a plurality of divided parts) for each stage from the part to the finished product. The divided illustration data of the robot or the like can be stored in the memory 32 of the mobile communication device 2 or an external memory (not shown) that can be attached.

Hereinafter, the operation of the medical support system 200 will be described in detail.
[2-2-1 Initial operation]
(1. Initial setting)
FIG. 35 shows operations of starting and initial setting of a medical support application (an example of a program; hereinafter, also simply referred to as an application) in the mobile communication device 2 according to the present embodiment.
First, the mobile communication device 2 starts up a medical support application installed in advance (S3501). At this time, the display unit 27 of the mobile communication device 2 displays information indicating the activation of the application as shown in the display example of FIG.
Then, the control unit 26 of the mobile communication device 2 initializes the illustration update flag and the sleeping screen display flag, and turns them off (S3502).

Next, the control unit 26 determines whether or not the initial setting (setting of user information) for the activated medical support application has been completed (S3503).
When the initial setting is not performed, that is, when the medical support application is started for the first time, the display as shown in FIG. 9 (user information setting display in the initial setting mode) is performed on the display unit 27 (S3504).
The user (mainly a doctor) inputs patient information such as the user ID 49, ID password 74, setting password 72, height, weight, date of birth, etc. of the patient according to the display, and operates the OK key 45 (S3505). ).
Next, the control unit 26 of the mobile communication device 2 determines whether or not the device registration setting between the mobile communication device 2 and the medicine injection device 1 has been completed (S3506). This device registration setting is specifically executed by an operation shown in FIG.

If the device registration is unregistered, the display 27 displays the same as in the first embodiment as shown in FIG. 10 (device setting display in the initial setting mode) (S3507). As shown in FIG. 10, a new registration key 46 for the medicine injection device 1, a parent operation key 47 for setting an operation mode, and a child operation key 48 are displayed on the display unit 27. After selecting those keys or inputting information, the OK key 51 is selected. Here, first, a new registration key 46 for device registration is selected (S3508). If it is determined in S3506 that the device registration setting has been completed, the new registration key 46 in FIG. 10 is displayed as a registration change (S3509). In the initial state, it is assumed that the operation mode is set to the parent mode. First, a new registration key 46 for device registration is selected (S3508). Then, the operation proceeds to the operation shown in FIG.

FIG. 36 shows a device registration setting operation between the mobile communication device 2 and the medicine injection device 1.
As shown in FIG. 11, the control unit 26 of the mobile communication device 2 performs a display prompting the user to hold the mobile communication device 2 over the medicine injection device 1 (also referred to as an injector) (S3601).
Then, the communication unit 37 (NFC IC or the like) for near field communication of the mobile communication device 2 is activated (S3602).
In this state, when the user holds the portable communication device 2 over the drug injection device 1 (closes it), the communication unit 19 of the drug injection device 1 is activated (S3603).
Further, in the mobile communication device 2, a search command is transmitted from the communication unit 37 to the communication unit 19 of the medicine injection device 1 (S3604).

Then, the communication unit 19 of the medicine injection device 1 receives this search command (S3605), and then the command is analyzed by the control unit 13 (S3606), and a response is sent from the communication unit 19 to the portable communication device 2. It transmits toward the communication part 37 (S3607).
Then, the control unit 26 of the mobile communication device 2 receives the response (S3608), and determines whether or not it is the drug injection device 1 (S3609). If it is determined that the drug injection device 1 is appropriate, a setting data write command is transmitted from the communication unit 37 of the portable communication device 2 to the communication unit 19 of the drug injection device 1 (S3610).
When the communication unit 19 receives this command at the communication unit 19 (S3611), the control unit 13 of the medicine injection device 1 analyzes the command (S3612) and stores the setting data in the memory 20 (S3613). Thereafter, a setting completion notification is transmitted from the communication unit 19 to the communication unit 37 of the mobile communication device 2 (S3614).

The control unit 26 of the mobile communication device 2 receives the setting completion notification via the communication unit 37 (S3615), and determines whether the device registration setting is completed (S3616). When the device registration setting is completed, it is further determined whether or not the initial setting is being performed (S3617). If the initial setting is being performed, the process proceeds to S3509 in FIG. 35, and if not, the process proceeds to S3514 in FIG.
Device registration between the mobile communication device 2 and the medicine injection device 1 is set by the above operation. That is, the mobile communication device 2 is in a state where it is determined that the device has been registered in S3506 of FIG.
In S3506 of FIG. 35, when the control unit 26 of the mobile communication device 2 determines that the device has been registered, the display unit 27 displays a screen displaying the new registration key 46 of FIG. 10 as registration change as described above. (S3509).

After that, the user selects the parent operation key 47 and the child operation key 48 (selects by touching or pressing down), inputs or changes the mail address as necessary (S3510), and then OKs in FIG. When the key 51 is selected (S3511), the initial setting is completed (S3513). It should be noted that the initial setting is not completed even if the OK key 51 is selected after selecting those keys or inputting information without performing device registration (S3512).
When the initial setting is completed, the process proceeds to S3514 in FIG.
(2. Authentication process)
In S3514 of FIG. 35, the control unit 26 of the mobile communication device 2 transmits user registration information (including patient registration information) to the communication unit 81 of the server 4 via the communication unit 25 and the network (S3514).

The control unit 82 of the server 4 receives the user registration information via the communication unit 81 (S3515), checks the registration information (S3516), and sends a response from the communication unit 81 to the communication unit 25 of the mobile communication device 2. The data is transmitted via (S3517). This is an authentication process for users (including patients) in the server 4.
The control unit 26 of the mobile communication device 2 receives this response via the communication unit 25 (S3518), and determines whether the user authentication with the server 4 is successful (S3519). If the received response is “OK”, the process proceeds to S 3701 in FIG. 37 to exchange patient use information between the mobile communication device 2 and the server 4.
On the other hand, if the authentication fails (in S3519, if the received response is “OK”), an authentication error is displayed on the display unit 27, for example, as shown in FIG. After the elapse of 3 seconds, the application is forcibly terminated (S3521).

(3. Registration of patient use information)
FIG. 37 is a flowchart showing communication processing between the mobile communication device 2 and the server 4 for registering user (patient) use information (hereinafter referred to as patient use information) in the server 4, and FIG. This is one of the two features. The patient usage information includes, for example, data indicating the usage state shown in the display of FIG.
First, the control unit 26 of the mobile communication device 2 determines whether patient use information is registered in the server 4 in S3701.
Here, when the patient use information is not registered (unregistered) in the server 4, the control unit 26 sends a request for registering the patient use information obtained from the drug injection device 1 in the server 4 to the portable communication device. 2 is transmitted from the communication unit 25 to the communication unit 81 of the server 4 (S3702).

Then, the control unit 82 of the server 4 receives this registration request via the communication unit 81 (S3703), and registers patient use information in the external storage device 86 (S3704). The control unit 82 transmits a registration completion notification from the communication unit 81 to the communication unit 25 of the mobile communication device 2 (S3705).
The control unit 26 of the mobile communication device 2 receives this registration completion notification (S3706). Thereby, the registration process of the patient use information in the server 4 is completed.
On the other hand, if the control unit 26 determines in S3701 that the patient use information is registered in the server 4, the control unit 26 proceeds to S3707.
In S <b> 3707, the control unit 26 transmits a patient use information acquisition request from the communication unit 25 to the communication unit 81 of the server 4 in order to confirm the registered patient use information.
Then, the control unit 82 of the server 4 receives the acquisition request (patient use information acquisition request) from the mobile communication device 2 (S3708). Next, the mobile communication device 2 still does not respond to the acquisition request. It is determined whether or not the server 4 has new patient usage information that is not registered (not yet updated) (S3709). For example, when the mobile communication device 2 breaks down and a new mobile communication device 2 is used, the user ID 49, ID password 74, and setting password 72 of the new mobile communication device 2 (FIG. 9 or FIG. Although not changed, the previous patient use information may be lost in the memory 32 of the mobile communication device 2. Therefore, when the server 4 has patient usage information that is not yet registered in the mobile communication device 2, the control unit 82 of the server 4 acquires the patient usage information stored in the external storage device 86 (S3710). ), The information is transmitted from the communication unit 81 to the communication unit 25 of the mobile communication device 2 (S3711).

Then, the control unit 26 of the mobile communication device 2 receives the patient use information via the communication unit 25 (S3712) and stores it in the memory 32 (S3713). Thereafter, the control unit 26 sets the illustration update flag to ON (S3714).
In S3709, in a normal case (when the patient use information matches between the mobile communication device 2 and the server 4), the control unit 82 of the server 4 has already transferred from the communication unit 81 to the communication unit 25 of the mobile communication device 2. A notification to the effect that registration of patient use information has been completed (in the example of FIG. 37, notification of completion of patient use information transmission) is transmitted (S3716).
The control unit 26 of the mobile communication device 2 determines whether or not the registration of the patient use information is completed by receiving the patient use information transmission completion notification (S3715).
If the patient use information transmission completion notification has not been received, the patient use information may still remain in the server 4. Therefore, the control unit 26 returns to the step of transmitting the above-described patient use information acquisition request to the server 4 (S3707). Returning to S3707, a patient use information acquisition request is transmitted to the communication unit 81 of the server 4 from the portable communication device 2 as described above again. The control unit 82 of the server 4 receives the acquisition request (S3708), and acquires patient use information and the like from the external storage device 86 if there is patient use information not yet registered in the mobile communication device 2 (S3709, S3710). The unregistered patient use information is transmitted from the communication unit 81 to the communication unit 25 of the mobile communication device 2 (S3711).

The control unit 26 of the mobile communication device 2 receives this patient use information (S3712), registers the received patient use information in the internal memory 32 (S3713), and sets the illustration march flag to ON (S3714). .
In S3715, when the completion notification is received, the process proceeds to S3801 in FIG.
[2-2-2 Drug injection operation]
In addition, after the above initial setting is completed, the injection | pouring of chemical | medical agents, such as a growth hormone agent, is performed using the chemical | medical agent injection apparatus 1 shown in FIG. 24 similarly to the above-mentioned Embodiment 1. FIG.
As shown in FIG. 24, when the medicine injection in the preparation syringe 8 is completed by the medicine injection device 1, the medicine usage data (medical injection operation is performed) in the memory 20 connected to the communication unit 19 of the medicine injection device 1. And information on the injected drug (for example, drug dose, drug administration time, etc.) are recorded. The drug use data (included in the patient use information) is transmitted to the communication unit 37 of the mobile communication device 2 via the communication unit 19 of the drug injection device 1 using near field communication or the like. This medicine use data is also transmitted to the server 4 and the personal computer 5 via the portable communication device 2 and the network 3. At the time of this transmission (the operation of FIG. 39), the mobile communication device 2 needs to activate a medical support application.

The drug injection device 1, the mobile communication device 2, and the personal computer 5 are each provided with

communication units

19, 37, and 44 that perform near field communication. Distance communication can also be performed.
Of course, near field communication can also be performed between the mobile communication device 2 and the personal computer 5. Further, when the short-range communication from the medicine injection device 1 to the portable communication device 2 or the personal computer 5 or from the portable communication device 2 to the personal computer 5 fails, the display unit is similar to the display as shown in FIG. An error message is displayed at 27.
[2-2-3 Data acquisition / update indicating usage status]
FIG. 38 shows an operation of determining the use state of the pharmaceutical injection device 1 that is mainly executed by the control unit 26 of the mobile communication device 2 in accordance with the medical application program. It is assumed that the control unit 26 of the mobile communication device 2 has completed the above-described series of initial operations (S3502 to S3519 in FIG. 35 and S3601 to S3616 in FIG. 36). The following description is based on the assumption that the operation is shifted to the operation of FIG.

The control unit 26 of the mobile communication device 2 first determines whether the illustration update flag is ON / OFF (S3801). This illustration update flag is initialized (OFF) in S3502 of FIG. 35 when the application is activated. Therefore, immediately after the application is activated, the illustration update flag is determined to be OFF, and the process proceeds to S3814. If the illustration update flag is determined to be ON, the process proceeds to S3802, which will be described later.
In S3814, it is determined whether the bedtime screen display flag is ON / OFF. The sleeping screen display flag is also initialized (OFF) when the application is activated. Therefore, immediately after the application is activated, the bedtime screen display flag is determined to be OFF, and the process proceeds to S3815. On the other hand, when it is determined that the sleeping screen display flag is ON, the process proceeds to the operation shown in FIG.

When it is determined that the sleeping screen display flag is OFF, a different screen is displayed on the display unit 27 according to the set operation mode. That is, the operation mode is set through operation of an operation key displayed on the screen as shown in FIG.
In S3815, the control unit 26 selects a screen to be displayed on the display unit 27. For example, if the child mode is selected and set, a main screen for children is displayed on the display unit 27 as shown in FIG. 13 (S3816). However, in the case of the first administration, the robot illustration in FIG. 13 is not displayed. If the parent mode is selected and set, a main main screen as shown in FIG. 15 is displayed on the display unit 27 (S3819).
In any of these cases, when the user selects the data acquisition key 52 (FIGS. 13 and 15) displayed on the display unit 27 (S3817, S3820), the display unit 27 displays the mobile communication as shown in FIG. A display that prompts the device 2 and the medicine injection device 1 to come close to each other is displayed. And the portable communication apparatus 2 transfers to the acquisition operation | movement of the chemical | medical agent use data shown in FIG. 39 mentioned later.

Further, when the control unit 26 detects that the sleep (sleeping) key (reference numeral 69 in FIGS. 13, 15, and 16) is selected (S3818, S3821), acquisition of bedtime information in FIG. Move to operation.
Further, when the control unit 26 detects that the setting key 73 (FIGS. 15 and 16) is selected when the operation mode is set to the parent mode (S3822), the setting data shown in FIG. Move to input operation.
In the following, each operation for obtaining / updating usage data will be described.
(1. Acquisition of drug use data)
39, after the user selects the data acquisition key 52 (FIGS. 13 and 15) displayed on the display unit 27 of the mobile communication device 2 (S3817 and S3820 in FIG. 38), the drug use data from the drug injection device 1 is displayed. The operation for acquiring is shown.

On the screen of the display unit 27, as shown in FIG. 11, a display for prompting the mobile communication device 2 and the medicine injection device 1 (also referred to as an injector) to approach each other is made (S3901).
Then, the communication unit 37 (NFC IC in the example of FIG. 6) for short-distance communication of the mobile communication device 2 is activated (S3902), and in this state, the user calls the mobile communication device 2 a drug injection device (an injector). ) 1, the communication unit 19 (NFC IC in the example of FIG. 5) of the pharmaceutical injection device 1 is activated (S3903).
In the mobile communication device 2, a search command is transmitted from the communication unit 37 to the communication unit 19 of the medicine injection device 1 (S3904). Then, the communication unit 19 of the drug injection device 1 receives this search command (S3905), and subsequently analyzes the command by the control unit 13 of the drug injection device 1 (S3906) and sends a response from the communication unit 19 It transmits toward the communication part 37 of the portable communication apparatus 2 (S3907).

Then, the control unit 26 of the mobile communication device 2 receives the response via the communication unit 37 (S3908), determines whether or not it is the drug injection device 1 (S3909), and an appropriate drug injection device. If it is 1, the medicine use data read command is transmitted from the communication section 37 to the communication section 19 of the medicine injection device 1 (S3910).
When the communication unit 19 receives this command at the communication unit 19 (S3911), the control unit 13 of the drug injection device 1 analyzes the command (S3912) and acquires drug use data from the memory 20 (S3913). Thereafter, the medicine use data is transmitted from the communication unit 19 to the communication unit 37 of the mobile communication device 2 (S3914).
The drug use data refers to information related to drug injection (drug use data). For example, whether or not the drug has been administered (injection), the dose (injection) of the drug, the administration (injection) time, etc. Means information and included in the patient use information described above. Further, when this medicine use data is stored in the memory 18 of the medicine injection device 1, the medicine use data is acquired from the memory 18.

The communication unit 37 of the mobile communication device 2 receives the drug use data including the drug injection record recorded in the memory 20 or the like of the drug injection device 1 by short-range communication with the communication unit 19 of the drug injection device 1 ( S3915).
Next, the control unit 26 of the mobile communication device 2 determines whether or not the received medicine use data is not received (that is, the medicine use data received for the first time) (S3916).
If new drug use data has been received, the process proceeds to S3917. If not, the process proceeds to the operation in FIG.
When new drug use data is received, the process proceeds to S3917, where a process (patient use information construction process) for constructing the display data as shown in FIGS. 13 and 15 is performed (S3917), It is stored in the memory 32 (S3918).

Thereafter, the process proceeds again to S3910 to S3916. In this S3916, since there is no unreceived data, the mobile communication device 2 then proceeds to the drug administration time data generation / update operation shown in FIG. . This will be described later.
(2. Acquisition of bedtime information)
In FIG. 38, the control unit 26 of the mobile communication device 2 detects that the sleep (sleeping) key (reference numeral 69 in FIGS. 13, 15, and 16) is selected (S3818, S3821). Move to operation.
FIG. 41 shows an operation for acquiring the actual bedtime information of the patient. In S4101, a bedtime key 69 is displayed on both the main screen for children of FIG. 13 and the main screen for parent of FIG. 15, and thus this bedtime key 69 is selected after drug administration.

Then, the control unit 26 acquires date and time information of the time when the bedtime key 69 is pressed (S4101), and performs patient use information construction processing (S4102). That is, in S4102, patient usage information is constructed from the drug usage data (including the time of injection) and the bedtime, and is stored in the memory 32 of the mobile communication device 2 (S4103).
Next, the illustration update flag is set to ON (S4104), and the sleeping screen display flag is set to ON (S4105).
Subsequently, the mobile communication device 2 proceeds to the drug administration time data generation / update operation shown in FIG. This will be described later.
(3. Setting data input)
FIG. 42 shows each setting data after the user (mainly a doctor) selects the setting key 73 (FIGS. 15 and 16) displayed on the display unit 27 (parent / doctor setting screen) of the mobile communication device 2. The operation to input is shown. When the control unit 26 of the mobile communication device 2 detects that the setting key 73 is selected (S3822 in FIG. 38), for example, the screen illustrated in FIG. 18 is displayed on the display unit 27 (S4201).

This setting screen includes an alarm valid key 55 (“On” key in the example of FIG. 18), an alarm invalid key 56 (“Off” key in the example of FIG. 18), and a recommended bedtime setting unit for setting the administration alarm. 57, bedtime interval setting unit 58 after administration (infusion), bedtime effective range setting unit 59, morning administration setting unit 60, drug efficacy period setting unit 61, achievement degree increase / decrease (achievement degree increase / decrease point in the example of FIG. 18) setting part 62, an illustration update setting unit 63, an illustration evolution setting unit 64, an automatic end setting unit 65, a save key 66 for saving these setting information, and the like are displayed (S4201). Each setting data is set by the user (mainly a doctor) selecting or inputting data via this setting screen. It should be noted that the recommended bedtime setting unit 57, the bedtime interval setting unit 58 after administration (infusion), the bedtime effective range setting unit 59, the morning administration setting unit 60, the drug efficacy period setting unit 61, the achievement rate increase / decrease (in the example of FIG. When the parent sets the achievement level increase / decrease point) setting unit 62, the illustration update setting unit 63, and the illustration evolution setting unit 64, it may be set by inputting a setting password.

The alarm valid key 55 is for causing the display unit 27 to display such as shown in FIG. 17 at the scheduled administration (injection) time, and the alarm invalid key 56 is for canceling it. belongs to. By selecting any key, the administration alarm is set to be valid / invalid (S4202). The notification of the alarm may be a display on the display unit 27 (for example, LED lighting / flashing, display on the screen with characters, graphics, or the like), or may be performed by sound or vibration.
When the set alarm time is reached, a display informing the drug administration is made on the display unit 27 (see FIG. 17), and the alarm is ended when the end key 71 is pressed. At this time, if the “snooze” key 79 is pressed, the alarm is temporarily stopped, and after a predetermined time, the “administration alarm” is activated again.

The recommended bedtime setting unit 57 is a part for setting a recommended bedtime for each age, and performs recommended bedtime setting (S4203).
Next, the post-administration sleep interval setting unit 58 sets an interval until bedtime after drug administration (drug injection) and depends on the efficacy of the drug, and is set here (S4204).
The next bed effective range setting unit 59 sets achievement degree addition conditions (effective range of time from drug injection to bed: for example, bed time-drug administration time ≦ sleep interval after drug administration ± sleep effective range). Yes, settings are made here (S4205). For example, if the drug administration time is 1.5 hours before bedtime, and the bedtime interval after drug administration is 1 hour and the bedtime effective range is within +/− 30 minutes, bedtime-drug administration time = 1.5 hours, so the achievement degree addition condition is satisfied.

Next, the morning administration setting unit 60 sets the morning administration time (for example, 7 am) on the next day when the drug administration is forgotten, and the setting is performed here (S4206).
The drug efficacy period setting unit 61 sets the time during which the administered drug is effectively used in the body, and is set here (S4207).
The achievement level increase / decrease setting unit 62 is a part for increasing the points when the bedtime is within the valid range (for example, 30 minutes, etc.). Here, the setting is performed (S4208). For example, the illustration displayed on the display unit 27 is updated based on the increase in the number of points.
Next, the illustration update setting unit 63 sets the frequency (number of days, etc.) of updating the illustration on the display unit when achievement level increase / decrease points are continuously added, and the setting is performed here. (S4209). As an example, when the set value for this illustration update is “3 days”, the illustration is updated when the above point addition is continued for 3 days. That is, as shown in FIG. 13, for example, an illustration of a robot is displayed on the display unit 27, and if appropriate medicine is continuously administered for a predetermined period, the illustration is updated as shown in FIG. 14. Of course, the illustrations in the main main screen display of FIGS. 15 and 16 are also updated.

Next, the illustration evolution setting unit 64 is for setting the frequency (number of days etc.) by which the illustration of the robot shown in FIG. 14 is changed, and setting is performed here (S4210). In this example, if appropriate drug administration is executed continuously for one month, illustration data of a new robot (for example, a new robot that has evolved) is acquired, and the illustration displayed on the display unit 27 is changed. ing.
Next, the automatic termination setting unit 65 is for setting a time for automatically terminating this application at bedtime, and the setting is performed here (S4211).
If the save key 66 is selected after setting these setting data (S4212), the setting information of FIG. 18 is saved in the memory 32 of the mobile communication device 2 (S4213).
Although not particularly illustrated, after the save key 66 of FIG. 18 is selected, the control unit 26 causes the display unit 27 to display the screen of FIG. 20 for the doctor, and for the parent, 19 screens are displayed. FIG. 20 shows patient physical information (height, weight, date of birth, etc.), device registration, operation mode setting, user ID, ID password, which are initially set by the doctor in FIG. 9 and FIG. It is a screen for making it possible to set a setting password, a dosage, and the like. FIG. 19 shows the conditions of the patient's physical information (height, weight, date of birth, etc.), user ID, etc., initially set by the parent in FIGS. 9 and 10, and device registration, operation mode setting, mail address This is a screen for changing the settings. Note that it is possible to change the setting of the physical information by inputting a setting password. When the settings in FIGS. 19 and 20 are completed, the save key 68 is selected, and the updated setting information is saved in the memory 32 of the mobile communication device 2.

Subsequently, the mobile communication device 2 proceeds to the drug administration time data generation / update operation shown in FIG.
(4. Generation / update of drug administration time data)
FIG. 40 shows the data generation / update operation of the drug administration time.
The control unit 26 of the mobile communication device 2 determines whether or not there is a drug administration today from the drug use data received in S3915 of FIG. 39 (S4001). If there is drug administration today, the process proceeds to S4002, and if not, the process proceeds to S4009.
The control unit 26 determines whether or not the drug injection has been executed before the recommended time of drug injection saved by the input of the setting data (here, bedtime—sleep interval after administration) (S4002). According to the setting on the screen of FIG. 18, if the bedtime is 21 o'clock (9 pm), it is set so that the normal drug administration is carried out at 20 o'clock (8 pm) one hour before that. However, in S4002, it is determined whether the administration time is before or after 8:00 pm. Therefore, if today's administration time is after 8:00 pm, the process proceeds to S4003, and the next administration time is stored in the memory 32 as 8:00 pm (20:00) which is the normal administration time of tomorrow (S4006). ).

On the other hand, when the medicine administration time is, for example, 6:00 pm, the process proceeds from S4002 to S4004. In S4004, it is determined whether or not the administration time is within the drug efficacy period (in this example, 4 hours) minus 2 hours with respect to the normal drug administration time. For example, if the administration time is 6 pm, this condition is satisfied, and the process proceeds to S4003.
On the other hand, when the medicine administration time is, for example, 3 pm, the condition is not satisfied in S4004. Therefore, in S4005, the next medicine administration time is reset at 8:00 pm today and stored in the memory 32 in S4006. That is, if the drug (growth hormone drug) of this embodiment is not administered for 4 hours before going to bed, the efficacy of the drug will not be exerted. It is urged to administer the drug at 8 o'clock.

After S4006, the process proceeds to S4007 and S4008. That is, in S4007, it is determined whether the alarm setting is set. If the alarm setting shown in FIG. 18 is set, the alarm time is set in S4008. For example, in the case of administration at 3 pm as described above, an alarm is set so that an alarm sounds again at 8 pm in order to prompt the administration of the medicine again at 8 pm on that day.
On the other hand, when it is determined in S4001 that the last drug administration time is before the previous day (when there is drug administration by the previous day), the process proceeds to S4009. In that case, the control unit 26 determines whether or not drug administration is performed on the previous day (S4009). If there is no drug administration on the previous day, next time, the drug administration time is set tomorrow morning. (S4010). On the other hand, if the drug administration on the previous day is performed, the control unit 26 sets the next administration time to the normal time of tomorrow (for example, the drug administration time at 8:00 pm) (S4011), and proceeds to S4006 to 4008, The memory for the next administration time and alarm setting are performed in the same manner as described above.

After the alarm setting or the like is performed as described above, the operation of the control unit 26 of the mobile communication device 2 proceeds to S3801 in FIG.
[2-2-4 Usage status judgment]
(1. Update and display of illustration data)
The mobile communication device 2 determines the presence / absence (ON / OFF) of the illustration update flag (S3801).
In the present embodiment, when the drug is continuously administered by the illustration update setting unit 63 of FIG. 18 for a set period (for example, three days), the illustration is updated. For this reason, in S3801, if the control unit 26 determines that the illustration update flag is set to ON, the process proceeds to S3802. On the other hand, for example, if today is the first drug administration, since the illustration update flag is OFF in S3801, the process proceeds to S3814 as described above.

In S3802, the control unit 26 determines whether or not the actual drug administration time is within +/− 30 minutes of the bedtime (sleeping effective range setting unit 59 in FIG. 18). In S3802, if the medicine administration time is within the set time, the process proceeds to S3803 and achievement points are increased. Then, it is determined whether or not this is a point up for three consecutive days (FIG. 18) (S3804), and if there is a point up for three consecutive days, the illustration is updated (S3805). In other words, the robot illustration 75 shown in FIG. 13 is updated so as to be assembled into a finished product, like the illustration 76 shown in FIG.
On the other hand, if the actual drug administration time is out of the set range in S3802, the control unit 26 performs point-down in S3806 and moves the illustration backward in S3807. That is, the robot illustration 76 shown in FIG. 14 is changed to the original state as shown in the illustration 75 of FIG.

As a result of repeating S3805, for example, if it is determined that the point-up for one month has been achieved (S3808), the control unit 26 sends an illustration change request to the new robot from the communication unit 25 to the communication unit 81 of the server 4. (S3809).
Upon receiving this illustration change request via the communication unit 81 (S3810), the control unit 82 of the server 4 transmits evolution illustration data to the communication unit 25 of the mobile communication device 2 (S3811). .
The control unit 26 of the mobile communication device 2 receives the evolution illustration data via the communication unit 25 (S3812). The received information is stored in the memory 32.
In this state, the control unit 26 clears (OFF) the illustration update flag in S3813. Thus, a new illustration (for example, an evolved robot) is displayed on the screen display for children in FIGS.

Of course, the illustrations in the main main screen display of FIGS. 15 and 16 are also updated or changed.
Subsequently, in S3814, when the control unit 26 determines that the sleeping screen display flag is ON, the control unit 26 proceeds to S4301 in FIG. The bedtime display flag is set to ON when the bedtime key 69 is selected in FIG. 13 or 15 (S3818, S3821) and bedtime information is acquired (S4105 in FIG. 41).
If it is determined in S3814 that the sleeping screen display flag is OFF, the process proceeds to S3815 and the process described above. If it repeats, if child mode is selected in S3815, a display as shown in FIG. 13 will be made on the display part 27 (S3816), and if the parent mode is selected, it will be shown in FIG. Such a display is made (S3819).

When this S3816 (child screen) is displayed, the control unit 26 detects that the injection data acquisition key 52 shown in FIG. 13 has been selected (S3817), as described above, S3901 of FIG. Migrate to If it is detected that the good night key 69 (FIG. 13) is selected (S3818), the process proceeds to S4001 in FIG. 41 as described above.
On the other hand, when S3819 (parent / doctor screen) is displayed, if it is detected that the injection data acquisition key 52 shown in FIG. 15 is selected (S3820), as described above, S3901 in FIG. Migrate to If it is detected that the sleep key 69 (FIGS. 15 and 16) is selected (S3821), the process proceeds to S4101 in FIG. 41 as described above. Further, when it is detected that the setting key 73 has been selected (S3822), the process proceeds to S4201 in FIG. 42 as described above.

(2. Achievement evaluation display)
As described above, when it is determined in S3814 in FIG. 38 that the sleeping screen display flag is ON, the process proceeds to S4301 in FIG.
FIG. 43 shows an operation of generating and displaying display data corresponding to the degree of continuous achievement of the proper use state of the pharmaceutical injection device 1.
In S4301 of FIG. 43, the control unit 26 determines an increasing tendency of the achievement level. First, when drug administration is appropriately performed for three consecutive days, the control unit 26 causes the display unit 27 to display a compliment (a word to encourage) as shown in FIG. 14 in S4302 of FIG. Set. In addition, when the drug administration has been appropriately performed for only two days, the control unit 26 sets the display unit 27 to display a word (advice) for prompting continuous execution in S4303. On the contrary, the control unit 26 is configured to display on the display unit 27 a word that prompts the drug administration to be performed continuously (administration instruction) when appropriate drug administration is not continuously performed. (S4304).

Then, after these processes of S4302, S4303, and S4304, the control unit 26 clears the sleeping screen display flag (S4305). Then, the above-described advice message is displayed on the display unit 27 as shown in FIG. 14, for example (S3206).
Thereafter, when it is determined that a predetermined time (one minute in the example of FIG. 43) has elapsed (S4307), the control unit 26 ends the display on the display unit 27 and ends the application.
Further, during this time, when the end key 70 in FIG. 14 is operated (S4308), the display of the display unit 27 is ended at that time, and the application is ended.
[2-3 Effects, etc.]
As described above, in the present embodiment, the control unit 26 of the mobile communication device 2 communicates with the communication unit 19 of the drug injection device 1 through the communication unit 37, and the usage state of the drug injection device 1 is stored in the memory 32. In addition to recording, when it is determined by the control unit 26 of the mobile communication device 2 that the use state of the drug injection device 1 is appropriate, the medicine injection device 1 displayed on the display unit 27 of the mobile communication device 2 Update the appropriate usage indication to the plus side.

For this reason, if the medicine injection device 1 is appropriately used, the appropriate use display of the medicine injection device 1 displayed on the display unit 27 of the mobile communication device 2 is updated to the plus side. 1 can be easily grasped, and the user's awareness of continuous use of the pharmaceutical injection device 1 can be improved.
Further, in the server 4 that can communicate with the portable communication device 2, the user information, the drug use information of the drug injection device 1 (the drug use data acquired from the drug injection device 1 via the portable communication device 2, the drug efficacy). (Including information), information about sleeping, etc. and illustration data are managed. Therefore, it is possible to reduce the management burden on the mobile communication device 2 side and the burden of setting changes in the case of a failure or replacement of the mobile communication device 2.
[2-4 Modifications]
In the above embodiment, the use state determination process of the pharmaceutical injection device 1 is executed by the control unit 26 of the mobile communication device 2 according to the program of the medical application, but the control unit 82 of the server 4 (medical support) It may be executed by an example of an apparatus.

In this case, the control unit 82 (an example of the second control unit) of the server 4 executes the processes of S3802 to S3808 in FIG. 38 based on the registered patient use information, updates or changes the illustration data, The updated or changed illustration data may be transmitted to the mobile communication device 2 in response to the transmission request and displayed on the display unit 27.
(Embodiment 3)
Next, Embodiment 3 will be described below. In addition, about the structure or function similar to

Embodiment

1 and 2, the same code | symbol is attached | subjected and description is abbreviate | omitted.
In the first and second embodiments, the determination to update the illustration is based on whether or not the actual drug administration time is within a predetermined time before going to bed (S2702 in FIG. 27 or S3802 in FIG. 38). It is not limited. For example, the achievement level may be calculated based on the dose of the drug in addition to or instead of this condition.

In the present embodiment, the actual dose of the growth hormone agent is compared with the dose set by a doctor or the like, and whether or not the patient (user) has appropriately used the drug injection device 1 according to the difference. Determine.
Hereinafter, this embodiment will be described in detail.
[3-1 Configuration]
The configuration of the medical support system according to the present embodiment is the same as that of the medical support system 100 according to the first embodiment (FIG. 1) or the medical support system 200 according to the second embodiment (FIG. 33). Omitted.
The configuration of the drug injection device according to the present embodiment is the same as that of drug injection device 1 (FIGS. 2 to 5) according to the first or second embodiment, and a description thereof will be omitted.

Since the configuration of the mobile communication device according to the present embodiment is the same as that of mobile communication device 2 (FIG. 6) according to

Embodiment

1 or 2, description thereof is omitted.
[3-2 Operation]
[3-2-1 Setting screen]
FIG. 44 shows an example of a device setting screen displayed on the display unit 327 of the mobile communication device 2 according to the present embodiment. The device setting screen is displayed on the display unit 327 when the medical application program is executed by the control unit 26 of the mobile communication device 2. The device setting screen is the same as the screen of FIG. 20 and is an input screen mainly for doctors. The device setting screen is displayed, for example, after the initial setting is completed and the setting key 73 is selected on the parent screen (FIGS. 15 and 16) (S2719 in FIG. 27 or S3822 in FIG. 38).

In response to the device setting screen, doctors, etc., in addition to patient information such as patient ID, date of birth, height, weight, etc., include disease type 391, drug (growth hormone) dose 392, and drug combination dose 393. Then, press the setting key 473. Thereby, the input information is set and registered.
The drug dose 392 may be automatically calculated and displayed by the medical application. For example, the dose of the drug is obtained from the patient's body weight according to the following formula.
Dose = body weight × unit dose per body weight (1 week) / weekly The dose of the drug is also obtained from the height of the patient according to the following formula. Height factor = 1 + (Growth curve height-Height) / 100
Dose = basal dose × height coefficient The body weight unit dose and the basal dose are determined by the dose of the drug or by the doctor.

The dose of the hormonal agent may need to be adjusted depending on the disease. Therefore, the dose of the hormone agent is adjusted according to the set disease type 392.
The dose of the hormonal agent may also need to be adjusted if the patient is, for example, osteoporosis and is taking oral medications. Therefore, the dose of the hormone agent is adjusted according to the set dose 393 at the time of combined drug use.
[3-2-2 Appropriateness of usage status]
FIG. 45 shows an operation for determining the appropriateness of the usage state of the pharmaceutical injection device 1 according to the present embodiment. FIG. 45 shows the processing when the illustration update flag is determined to be ON in FIG. 27 or FIG. 38. S2701, S2702, S2703, S2706 in FIG. 27, or S3801, S3802, S3803, S3806 in FIG. And the same processing.

In S4501, the control unit 26 (FIG. 6) of the mobile communication device 2 determines the presence / absence (ON / OFF) of the illustration update flag.
In the present embodiment, in the same manner as in the first and second embodiments, the illustration update setting unit 63 in FIG. 18 displays an illustration when the medicine is administered continuously for a set period (for example, three days). Updates are made. In S4501, when the control unit 26 determines that the illustration update flag is set to ON, the process proceeds to S4502. On the other hand, when the illustration update flag is OFF (for example, when today is the first drug administration), the process proceeds to S2711 in FIG. 27 or S3813 in FIG.
In step S4502, the control unit 26 determines the difference between the actual drug dose and the set drug dose, and determines whether the difference α is within an allowable range. If it is determined that the difference between the actual drug dose and the set drug dose is less than α, the process proceeds to S4503, and if not, the process proceeds to S4504.

The actual drug dosage is acquired from the drug injection device 1 as drug use data. At this time, as shown in FIG. 28 or FIG. 39, by bringing the mobile communication device 2 and the medicine injection device 1 close to each other, the communication unit 37 for short-range communication of the mobile communication device 2 (NFC in the example of FIG. 6). IC) and the communication part 19 of the medicine injection device 1 are communicated.
In S4503, the control unit 26 increases the achievement point, and proceeds to S2704 in FIG. 27 or S3804 in FIG.
In S4504, the control unit 26 performs achievement point down, and proceeds to S2707 in FIG. 27 or S3807 in FIG.
The above embodiment may be executed in addition to the achievement point up or point down of FIG. 27 or FIG.

[3-3 Effects, etc.]
In the above-described embodiment, in addition to the effects of the first and second embodiments, it is possible to determine the appropriateness of the usage state of the drug injection device 1 based on the dose of the drug, and the appropriate use according to the determination result Display can be performed. For this reason, the patient who is a user is prompted to administer an appropriate amount of medicine, and by achieving this, the awareness of continuous use of the medicine injection device 1 can be improved.
(Embodiment 4)
Next, Embodiment 4 will be described below. In addition, about the structure or function similar to

Embodiment

1 and 2, the same code | symbol is attached | subjected and description is abbreviate | omitted.
In the present embodiment, the preparation stored in the preparation syringe 8 of the drug injection device 1 is insulin that a diabetic patient injects into the human body. Therefore, unlike Embodiments 1 to 3, the suitability of the use state of the drug infusion device 1 is determined according to data related to insulin administration, and an appropriate use display (an example of suitability information) according to the determination. ) To the plus side (update to appropriateness information with a higher level of appropriateness).

Hereinafter, this embodiment will be described in detail.
[4-1 Configuration]
The configuration of the medical support system according to the present embodiment is the same as that of the medical support system 100 (FIG. 1) or 200 (FIG. 33) according to the first to third embodiments, and a description thereof will be omitted.
The configuration of the pharmaceutical injection device according to the present embodiment is the same as that of the pharmaceutical injection device 1 (FIGS. 2 to 5) according to the first to third embodiments, but the preparation stored in the preparation syringe 8 is insulin. is there. Since other configurations are the same, description thereof is omitted.
The mobile communication device according to the present embodiment is the same as the mobile communication device 2 (FIG. 6) according to the first to third embodiments. Unless otherwise specified, the provided display screen is the same as that in the first to third embodiments.

[4-2 Operation]
[4-2-1 Setting screen]
46 (a) to 46 (c) show device setting screens displayed on the display unit 427 of the mobile communication device 2 according to the present embodiment. The device setting screen is displayed on the display unit 427 when the medical application program is executed by the control unit 26 of the mobile communication device 2. The device setting screen is the same as the screen of FIG. 20 and is an input screen mainly for doctors. The device setting screen is displayed, for example, after the initial setting is completed and the setting key 73 is selected on the parent screen (FIGS. 15 and 16) (S2719 in FIG. 27 or S3822 in FIG. 38).
FIG. 46A shows a screen 427a of the first page of the device setting screen. The screen 427a is a screen for mainly inputting patient information. FIG. 46B shows a screen 427b on the second page of the device setting screen. The screen 427b is a screen for inputting data related to the usage environment of the drug injection device 1 by the patient. FIG. 46C shows a screen 427c on the third page of the device setting screen. The screen 427c is a screen for inputting data related to the patient's life.

On the screen 427 a, the doctor or the like inputs a dose 492 of a medicine (insulin) in addition to patient information such as a patient ID, date of birth, height, and weight, and presses a setting key 473. Thus, the input information is set and registered, and the screen shifts to the screen 427b.
For the screen 427b, the doctors enter information such as the patient's wake-up time, timer after wake-up, sleep time, meal time (breakfast, lunch, dinner), post-administration timer, re-administration prohibited time, remind interval, etc. Press the key 473. Thus, the input information is set and registered, and the screen shifts to the screen 427c.
The set wake-up time is the time when the patient wakes up. The control unit 26 outputs an alarm at the time according to the setting of the wake-up time (sound, display, etc.).
The post-wake-up timer is the time that the patient should wait before administering insulin after waking up. By promoting insulin administration within a certain time after getting up, the so-called diabetes mellitus phenomenon is prevented.

The set sleep time is a sleep time in which the effect of insulin is not reduced due to lack of sleep, that is, the effect of insulin is obtained.
The set meal time is set to remind the patient when the meal time arrives.
The post-administration timer is the time until a meal or bedtime is taken after administration of insulin. This is a criterion for determining the appropriateness of administration timing.
The re-administration prohibition time is a time (a time during which insulin remains in the body) that must be released before the next administration after insulin administration. This is a criterion for determining the appropriateness of the administration timing and a criterion for determining the administration prohibition control of the drug injection device 1.
The remind interval is an interval for outputting an alarm or outputting the alarm again after a short pause (snooze function).

On the screen 427c, the doctor or the like inputs information such as the patient's total activity amount, exercise therapy activity, post-meal time for exercise therapy, duration, start timer, total calorie intake, and administration dose, and the like. Press 473. Thus, the input information is set and registered.
The set total amount of activity is an amount of exercise calculated from a patient's heart rate, number of steps, distance traveled by GPS, and the like. The patient's heart rate, number of steps, distance traveled by GPS, etc. may be obtained by reading from other applications installed in the mobile communication device 2 or obtained by a predetermined program provided in the medical application. You may make it do.
The set amount of exercise therapy activity is the amount of activity (calorie, etc.) that is regarded as the amount of exercise when the patient performs exercise therapy (walking, jogging, gymnastics, etc.). It is judged.

The set post-meal time for exercise therapy indicates the timing for starting exercise therapy after meal. The patient can effectively perform exercise therapy, for example by starting 1 hour after meals.
The set duration is the time for calculating the calorie of the actual amount of exercise therapy activity of the patient.
The start timer is the time from the exercise therapy start timing to the execution, and is the upper limit time that exercise therapy is considered effective.
The set total calorie intake is the amount of meal indicating the calorie intake at the time of the patient's dietary restriction. An appropriate amount of meal (calorie intake) for this patient may be input, or a predetermined food exchange table by a predetermined program provided in another application installed in the mobile communication device 2 or the medical application. You may make it calculate based on.

The setting dose is an appropriate insulin dose when the patient performs exercise therapy or dietary restrictions. The dosage at the time of setting may be input by the doctor, but is calculated based on the amount of exercise and the amount of meal set by another application installed in the mobile communication device 2 or a predetermined program provided in the medical application. You may make it do.
[4-2-2 Data acquisition when waking up]
FIG. 47 shows an operation for acquiring data (when the patient wakes up) that is a target for determining the appropriateness of the usage state of the pharmaceutical injection device 1 according to the present embodiment.
In S4701, the control unit 26 (FIG. 6) of the mobile communication device 2 determines whether or not the set wake-up time set on the screen 427b in FIG. 46B has come.
In S4702, when the set wake-up time is reached, the control unit 26 activates an alarm (alarm). The alarm is performed by sound or vibration. At this time, as shown in FIG. 48A, the display unit 427 wakes up and prompts the administration of insulin, but a screen is displayed. At this time, the patient presses the stop key 480 to stop the alarm. Alternatively, when the patient presses the snooze key 479, the alarm is once stopped, and after a predetermined time (corresponding to the remind interval set on the screen 427b in FIG. 46B, S4709 in FIG. 47), the alarm is activated again.

In S4703, the control unit 26 determines whether the alarm is stopped.
When the alarm is stopped in S4704, the display unit 427 displays a message prompting the user to input the physical condition of the day (for example, select one of good / normal / bad / sick day) as shown in FIG. 48 (b). Is displayed. The physical condition may be input at bedtime. In addition, the time from when the alarm is stopped until insulin administration, that is, the timer after waking up (the timer after waking up set on the screen 427b in FIG. 46B) is counted and displayed on the display unit 427.
In S4705, as shown in FIG. 48 (c), a message for prompting the mobile communication device 2 to approach the medicine injection device 1 is displayed. Thereby, communication is possible between the communication unit (NFC IC 37 in the example of FIG. 6) for short-range communication of the mobile communication device 2 and the communication unit (NFC IC 19 in the example of FIG. 5) of the medicine injection device 1. Thus, drug use data is transmitted from the drug injection device 1 to the portable communication device 2. The drug use data includes information such as the presence / absence of insulin administration (infusion), the amount of insulin administration (infusion), and the information on the infusion such as the administration (infusion) time).

In step S4706, the control unit 26 determines whether or not drug use data after waking up has been received from the drug injection device 1.
In step S4707, the control unit 26 stores the received medicine use data in the memory 32 or the like.
In step S4708, the control unit 26 determines that there has been administration after waking up, stops the alarm operation, and displays a message to start breakfast.
Although not shown, the actual wake-up time, sleep time, physical condition information, etc., which are patient life information, are sequentially acquired according to the input operation of the mobile communication device 2, sensor information, etc., as will be described later. And recorded in the memory 32 or the like.
[4-2-3 Data acquisition during meals]
FIG. 49 shows an operation of acquiring data (during a patient's meal) that is a target for determining the appropriateness of the usage state of the pharmaceutical injection device 1 by the mobile communication device 2 according to the present embodiment.

In S4901, the control unit 26 of the mobile communication device 2 receives the drug use data.
In S4902, the control unit 26 determines whether or not it is within 3 hours from the last time insulin was administered. If three hours have not elapsed, the process proceeds to S4903, and if it has elapsed, the process proceeds to S4904.
In S4903, the control unit 26 outputs a warning. That is, if insulin is administered within the re-administration prohibition time (the re-administration prohibition time set on the screen 427b in FIG. 46B) since the previous insulin administration, a warning is displayed. This warning may be displayed as a message or the like.
In S4904, the control unit 26 stores the received medicine use data and the count when a warning is issued in S4903 in the memory 32 or the like.

In S4905, the control unit 26 counts from the actual drug administration time included in the received drug use data to the actual meal start time. During this period, as shown in FIG. 48 (d), a message notifying the time until meal is displayed on the display unit 427.
In step S4906, a message for prompting a meal is displayed on the display unit 427. At this time, as shown in FIG. 48 (e), the display unit 427 displays the amount of meal (calorie intake) appropriate for the patient. Thereby, it is possible to prompt the patient who is on a diet therapy to have an appropriate meal.
In S4907, when the control unit 26 confirms that the meal has started in accordance with the operation of the patient, the process ends.
Although not shown, information such as actual meal time, meal amount (calorie intake), exercise amount (total activity amount, exercise therapy activity amount), exercise start time, and exercise duration, which are patient life information As will be described later, is sequentially acquired according to the input operation of the mobile communication device 2, sensor information, etc., and recorded in the memory 32 or the like.

[4-2-4 Usage status judgment]
FIG. 50 shows an operation of determining the appropriateness of the usage state of the pharmaceutical injection device 1 and the appropriateness of the patient's treatment life by the mobile communication device 2 according to the present embodiment.
In step S <b> 5001, the control unit 26 (FIG. 6) of the mobile communication device 2 determines whether it is an illustration update timing. This illustration update timing may be determined by the presence / absence of an illustration update flag (ON / OFF) as in the first to third embodiments, or may be set at a predetermined time (before going to bed or the like).
In the present embodiment, the illustration is updated when insulin is appropriately administered continuously for a preset period (for example, 3 days). If the control unit 26 determines in S5001 that the illustration update timing is reached, the process proceeds to S5002.

In S5002, the control unit 26 performs achievement level calculation processing. Details of the achievement level calculation process will be described later.
In S5003, the control unit 26 records the achievement point up or point down by the achievement calculation processing in S5002.
In S5004, the control unit 26 determines whether or not the points are continuously increased for three days.
In S5005, if there is a point up for three consecutive days, the control unit 26 advances the illustration. That is, the control unit 26 displays a child screen (not shown) on the display unit 427, and the illustration is completed so that the robot illustration 75 shown in FIG. 13 is shifted to the illustration 76 shown in FIG. Update to
In S5006, if there is a point down for three consecutive days, the control unit 26 moves the illustration backward. That is, the control unit 26 displays a main screen for children (not shown) on the display unit 427, and moves the illustration from the robot illustration 76 as shown in FIG. 14 to the illustration 75 as shown in FIG. Change to the state of.

In S5007, as a result of repeating S5005, the control unit 26 determines whether, for example, a point-up for one consecutive month has been achieved.
In S5008, when the point-up for the first month has been achieved, the control unit 26 changes the illustration to a new robot (for example, an evolved robot), and displays it on the display unit 427.
By the above processing, the updated illustration is displayed on the screen display for children as shown in FIGS. The illustrations in the parent screen display as shown in FIGS. 15 and 16 are also updated or changed.
In S5009, the control unit 26 determines an increasing tendency of the achievement level.
In S5010, for example, when the insulin administration is appropriately performed for three consecutive days, the control unit 26 sets the display unit 427 to display a compliment (a word to encourage) as shown in FIG.

In S5011, the control unit 26 sets the display unit 427 to display a word (advice) for prompting continuous execution when, for example, insulin administration is appropriately performed for only two days.
In S5012, the control unit 26 is set to display on the display unit 427 a message to the effect that the insulin administration is continuously performed (administration instruction) when appropriate insulin administration is not continuously performed. To do.
These display data may be stored in advance in a plurality of memories and output according to conditions.
After these processes of S5010, S5011, and S5012, the control unit 26 causes the display unit 427 to display the above-described advice message as shown in FIG. 14, for example.

Note that, when the server 4 is included in the medical support system as in the second embodiment, the following processing is executed.
If the control unit 26 of the mobile communication device 2 determines in S5007 that, for example, point-up for one month has been achieved, an illustration change request for a new robot is sent from the communication unit 25 to the communication unit 81 of the server 4 (FIG. 34). (Similar to S3809 in FIG. 38).
When the control unit 82 of the server 4 receives this illustration change request via the communication unit 81 (same as S3810), it transmits the evolution illustration data to the communication unit 25 of the mobile communication device 2 in response thereto. (Same as S3811).
The control unit 26 of the mobile communication device 2 receives the evolution illustration data via the communication unit 25 (same as S3812). Further, the received information is stored in the memory 32, and the process proceeds to S5009.

[4-2-5 Achievement calculation processing]
(1. Judgment process based on drug use data)
Hereinafter, an example of determination processing based on drug use data (information such as presence / absence of insulin administration (injection), insulin administration (infusion) amount, administration (infusion) time, etc.)) transmitted from the drug injection device 1 to the mobile communication device 2 It is.
(1-1) Actual medication time-Actual wake-up time <30 minutes (post-wake-up timer)
If the above conditions are satisfied, the achievement is pointed up, and if not, the achievement is pointed down. By promoting insulin administration within a certain time after waking up, the so-called diabetes mellitus phenomenon can be prevented.
(1-2) Actual meal start time-Actual medication time ≒ 30 minutes (post-dose timer)
This is a criterion for obtaining the effect of insulin. If the above conditions are satisfied, the achievement is pointed up, and if not, the achievement is pointed down.

(1-3) Presence / absence of medication within a certain period of time after waking up This is a criterion for preventing the so-called diabetes mellitus phenomenon. If there is no medication within a certain time after getting up, the achievement level is pointed down.
(1-4) If there is no medication within a certain time after getting up, whether there is a meal within the same fixed time.
(1-5) Actual dosing time-previous dosing time> 3 hours The time that insulin remains in the body is a criterion for avoiding re-administration. If the above conditions are not met (when a warning is received), the achievement will be pointed down.
(1-6) Presence or absence of medication or adjustment (reduction) of dosage when the patient's physical condition is “bad” or “sick day”
If there is no medication or if the dosage is reduced, the achievement is pointed up or maintained. For example, since it is necessary to refrain from administration of insulin when the patient's physical condition is not good, the appropriateness determination level is changed according to the patient's physical condition. Specifically, the level of the criterion is not changed when the physical condition is good, but the level of the criterion is lowered when the physical condition is not good.

(1-7) Dosage set at the time of exercise therapy and diet therapy = actual dose Compare the set dose at the time of execution (FIG. 46 (c)) with the actual insulin dose, and if there is no difference, the achievement level If there is a difference, point down the achievement level.
(2. Judgment process based on patient life information)
The following is an example of determination processing based on data related to a user managed by the mobile communication device 2.
(2-1) Actual sleep time-set sleep time> 0
If the above conditions are satisfied, the achievement is pointed up, and if not, the achievement is pointed down. This is a criterion for ensuring the sleep time in which the effect of insulin does not drop due to lack of sleep, that is, the effect of insulin is obtained. The actual sleep time is the time from the actual bedtime to the wake-up time. The bedtime may be input by the user, or the ambient illuminance is detected by the illuminance sensor 35 (FIG. 6) of the mobile communication device 2, and the presence / absence of the movement or the turnover is also detected by the acceleration sensor. Thus, the user's bedtime may be determined.

(2-2) Set meal time ≒ Actual meal time In order to determine whether regular eating habits (morning, noon, evening) are being executed, if the above conditions are met, the achievement is pointed up, otherwise Points down achievement.
(2-3) Actual total activity-set total activity> 0
This is a criterion for determining whether the patient has an appropriate amount of exercise. If the above conditions are satisfied, the achievement is pointed up, and if not, the achievement is pointed down. Depending on the difference, the degree of point-up or point-down may be differentiated.
(2-4) Actual exercise therapy activity amount−set exercise therapy activity amount> 0
It is a criterion for determining whether a patient is properly performing exercise therapy. If the above conditions are satisfied, the achievement is pointed up, and if not, the achievement is pointed down. Depending on the difference, the degree of point-up or point-down may be differentiated.

(2-5) Actual exercise therapy start time-last meal time ≈ 60 minutes This is a criterion for determining whether the patient is performing effective exercise therapy. If the above conditions are satisfied, the achievement is pointed up, and if not, the achievement is pointed down.
(2-6) Exercise therapy duration> 30 minutes This is a criterion for determining whether a patient is performing effective exercise therapy. If the above conditions are satisfied, the achievement is pointed up, and if not, the achievement is pointed down.
(2-7) Set total calorie intake-actual total calorie intake> 0
If the above conditions are satisfied, the achievement is pointed up, and if not, the achievement is pointed down. Depending on the difference, the degree of point-up or point-down may be differentiated. The control unit 26 calculates the actual total calorie intake based on a predetermined food exchange table or the like by a patient input or another application installed in the mobile communication device 2 or a predetermined program provided in the medical application. To do.

Note that all of the above determination processing may be performed and points may be added, or only a part thereof may be performed.
As for the above (2-1), (2-3), (2-4), and (2-6), not only insulin but also hormone agents such as growth hormone are administered. Even in this case, it becomes a judgment criterion.
[4-3 Effects, etc.]
In the above embodiment, in addition to the effects of the first to third embodiments, in addition to the appropriateness of the use state of the drug injection device 1 for administering insulin, the user such as exercise therapy or diet therapy executed by the patient who is the user It is possible to determine the appropriateness of treatment life and to display appropriate use according to the determination result. For this reason, the user is prompted to appropriately exercise and / or dietary therapy, and by achieving this, the user can improve the consciousness of continuous use of the drug injection device 1 and the continuity of his / her own treatment.

[4-4 Modification]
(1)
Instead of the above embodiment or in addition to the above embodiment, temperature data and illuminance data of the drug injection device 1 may be acquired as drug use data and used as a criterion for determining appropriateness of the use state.
When the medicine injection device 1 is not used in an appropriate temperature environment or illuminance environment, the medicine (insulin) inside the syringe is damaged and the medicine effect is lowered. Therefore, whether or not the drug injection device 1 is used in an appropriate temperature environment may be used as a criterion for determining whether or not the patient is using the drug injection device 1 appropriately, and may be used to count up or count down the achievement level. .

In this case, the drug injection device 1 (FIG. 5) is provided with a temperature sensor and an illuminance sensor connected to the control unit 13. The control unit 13 acquires temperature data and illuminance data from the temperature sensor or the illuminance sensor every predetermined time and stores them in the memory 18 or the like. The stored temperature data and illuminance data are transmitted to the mobile communication device 2 as drug use data.
In this modification, in addition to or instead of the appropriateness of the use state of the drug injection device 1 for administering insulin, it is determined whether the patient who is the user is using the drug injection device 1 in an appropriate environment, Appropriate use display according to the determination result can be performed. For this reason, it is possible to prompt the user to appropriately use the drug injection device 1.
(2)
The control unit 26 may display the actual total calorie intake in a graph via the display unit 427. In this case, it may be displayed in comparison with the set total calorie intake. This allows the patient to confirm the appropriateness of his diet.

(Other embodiments)
As described above,

Embodiments

1 and 2 have been described as examples of the technology disclosed in the present application. However, the technology in the present disclosure is not limited to this, and can also be applied to an embodiment in which changes, replacements, additions, omissions, and the like are appropriately performed. Moreover, it is also possible to combine the components of the first and second embodiments to form a new embodiment.
Therefore, other embodiments will be exemplified below.
(1)
In the first and second embodiments, the determination to update the illustration is based on whether or not the actual drug administration time is within a predetermined time before going to bed (S2702 in FIG. 27 or S3802 in FIG. 38). It is not limited. For example, in addition to or instead of this condition, a combination of conditions such as having taken a sleeping time of a predetermined time or more and having a bedtime within the recommended bedtime + α (for example, 1 to 2 hours), You may judge. That is, the achievement level may be increased when these conditions are satisfied, and the achievement level may be decreased when these conditions are not satisfied.

(2)
In the first and second embodiments, when the initial setting screen (FIG. 9), which is a screen mainly input by the doctor, is displayed, the control unit 26 of the mobile communication device 2 displays the input age and height. For example, the dose of the medicine may be automatically calculated.
(3)
In

Embodiments

1 and 2, the bedtime information is acquired by selecting a bedtime key (FIGS. 30 and 41), but may be acquired using other functions of the mobile communication device 2. For example, detection of sleeping by microphone input (confirmation of silent state), detection of turning over by an acceleration sensor (detection of stability for a predetermined time or more), detection of brightness by an illuminance sensor, and the like. Further, in addition to the selection of the bedtime key, by using these pieces of information, it may be detected whether or not the user has gone to bed reliably and used as bedtime information.

(4)
In the first to fourth embodiments, the registered user information may be transmitted from the medicine injection device 1 to the mobile communication device 2. In this case, for example, as shown in the display example of FIG. 12, user information is transmitted via short-range communication between the pharmaceutical injection device 1 and the portable communication device 2.
(5)
In Embodiments 1 to 4 described above, growth hormone agents and insulin are given as examples of drugs to be administered, but are not limited thereto. For example, the drug injection device may be an osteoporosis drug.
(6)
In the first to fourth embodiments, the suitability may be evaluated by not performing the achievement point down (that is, without changing the points) instead of the achievement point down.

Even in this case, since the appropriate use display of the medicine injection device displayed on the mobile communication device is updated to the plus side, it is possible to improve the user's continuity of treatment awareness.
(7)
The execution order of the operations and processes in the first to fourth embodiments is not necessarily limited to the above description, and the execution order can be changed without departing from the gist of the invention.
(8)
The present invention can be realized not only as a medical support system but also as a medical support device, a medical support method, or a computer program (or a computer-readable recording medium on which the program is recorded). The medical support apparatus may be a single chip that includes a part or all of it by an IC or the like.

The present disclosure can be used as a medical support system including a medical device such as a drug injection device for injecting a drug such as insulin or growth hormone and a portable communication device.

DESCRIPTION OF SYMBOLS 1 Drug injection apparatus 2 Mobile communication apparatus 3 Network 5 Personal computer 6 Main body case 7 Lid 8 Pharmaceutical syringe 9 Piston 10 Injection needle 11 Power switch 12 Injection switch 12A Operation switch 12Aa OK key 12Ab Down key 12Ac Up key 13 Control part 14 Drive motor 15 Motor drive circuit 16 Current detection circuit 17 Encoder 18 Memory 19 Communication unit 20 Memory 21 Battery 22 Display unit 23 Needle detection switch 24 Syringe detection switch 25 Communication unit 26

Control unit

27, 327, 427 Display unit 28 Touch panel 29 Power switch 30 Position information Detection unit 31 Sounder 32 Memory 33 Battery 34 Acceleration sensor 35 Illuminance sensor 36 Microphone 37 Communication unit 38 Communication unit 39 Control unit 40 Memory 41 Display device 42 Operation device 4 The external storage device 44 the communication unit 45 OK key 46 newly registered key 47 parent operation keys 48 children operation key 49 the user ID
50 Mail address input part 51 OK key 52 Data acquisition key 53 Mail transmission key 54 Cancel key 55 Alarm valid key 56 Alarm invalid key 57 Recommended bedtime setting part 58 Bedtime interval setting part after administration 59 Bedtime effective range setting part 60 Morning administration setting Part 61 Drug efficacy period setting part 62 Achievement increase / decrease setting part 63 Illustration update setting part 64 Illustration evolution setting part 65 Automatic end setting part 66 Save key 67 Save key 68 Save key 69 Sleep key 70 End key 71 End key 72

Setting password

73 , 373, 473 Setting key 74 ID password 75 to 78 Illustration display 79 Snooze key 81 Communication unit 82 Control unit 83 Memory 84 Display unit 85 Operating device 86 External storage device

Claims

A medical device used by a user, and a communication device capable of communicating with the medical device and acquiring usage information of the medical device;
With
The communication device includes a control unit, a display unit controlled by the control unit, and a memory,
The controller is
Recording usage information of the medical device in a memory;
Determining the appropriateness of the use state of the medical device based on the use information;
Appropriate information indicating the appropriateness level of the use state is displayed on the display unit,
When it is determined that the use state is appropriate, the appropriateness information displayed on the display unit is updated to the appropriateness information whose level of appropriateness has been increased.
Medical support system.
When the control unit determines that the use state of the medical device is appropriate multiple times continuously, the control unit displays the appropriateness information displayed on the display unit as appropriateness information with the appropriateness level increased. Update
The medical support system according to claim 1.
When the control unit determines that the use state of the medical device is inappropriate, the control unit updates the appropriateness information displayed on the display unit to appropriateness information with a reduced level of appropriateness.
The medical support system according to claim 1 or 2.
The appropriateness information indicates a finished product or a divided part of the finished product,
The control unit updates the appropriateness information displayed on the display unit in a stepwise manner from the divided part of the finished product toward the finished product.
The medical support system according to any one of claims 1 to 3.
When the control unit determines that the use state of the medical device is appropriate for a predetermined period of time, the control unit changes the appropriateness information displayed on the display unit to different appropriateness information.
The medical support system according to any one of claims 1 to 4.
The medical device is a drug injection device.
The medical support system according to any one of claims 1 to 5.
The medical device is a drug injection device for administering growth hormone,
The display unit of the communication device displays a bedtime input key for inputting the bedtime of the user.
The medical support system according to claim 6.
The communication device further includes:
An input unit that is controlled by the control unit and operated by a user; and a communication unit that is controlled by the control unit and communicates with other devices;
The control unit acquires the usage information via the input unit or the communication unit.
The medical support system according to any one of claims 1 to 7.
The use information is at least one of presence / absence of drug injection, drug dose, drug administration time, temperature data and illuminance data of the medical device,
The medical support system according to any one of claims 1 to 8.
The controller is
Determining the appropriateness of the use state of the medical device based on the time between at least one of the user's bedtime, wake-up time, meal time and the administration time of the drug;
The medical assistance system in any one of Claim 1 to 9.
The controller is
User life information including at least one of the user's wake-up time, meal time, sleep time, exercise amount, meal amount, exercise start time, and exercise duration time is acquired,
Determining the appropriateness of the user life based on the user life information;
The appropriateness information is generated based on the determined appropriateness of the user life and the appropriateness of the use state of the medical device, and is displayed on the display unit.
The medical assistance system in any one of Claim 1 to 10.
The controller is
Get physical condition information indicating the level of the user's physical condition,
Change the determination level of the appropriateness of the use state according to the physical condition information,
The medical assistance system in any one of Claims 1-11.
The usage information includes the dose of the drug,
The control unit determines the appropriateness of the use state of the medical device based on a comparison between the set dose of the drug and the dose of the drug included in the use information.
The medical support system according to any one of claims 1 to 12.
Medical devices used by users,
A communication device capable of communicating with the medical device and acquiring usage information of the medical device; and a server capable of communicating with the communication device and receiving the usage information of the medical device from the communication device;
With
The communication device includes a first control unit, a display unit controlled by the first control unit, and a first memory.
The server includes a second control unit and a second memory controlled by the second control unit,
The first control unit of the communication device includes:
Recording usage information of the medical device in a first memory;
Sending the usage information to the server;
The second control unit of the server is
Recording the usage information acquired from the communication device in the second memory;
The first control unit or the second control unit determines the appropriateness of the use state of the medical device based on the use information,
The first control unit displays appropriateness information indicating the appropriateness level of the usage state on a display unit of the communication device,
When the first control unit or the second control unit determines that the use state is appropriate, the first control unit displays the appropriateness information displayed on the display unit as the appropriateness. To update the appropriateness information to a higher level,
Medical support system.
When the first control unit or the second control unit determines that the use state of the medical device is appropriate continuously several times, the first control unit is displayed on the display unit. Updating the appropriateness information to appropriateness information with an increased level of appropriateness;
The medical support system according to claim 14.
When the use state of the medical device is determined to be inappropriate by the first control unit or the second control unit, the first control unit displays the appropriateness information displayed on the display unit. Is updated to the relevance information with the level of relevance lowered,
The medical support system according to claim 14 or 15.
The appropriateness information indicates a finished product or a divided part of the finished product,
The first control unit updates the appropriateness information displayed on the display unit stepwise from the divided part of the finished product toward the finished product.
The medical support system according to any one of claims 14 to 16.
When the first control unit or the second control unit determines that the use state of the medical device is appropriate for a predetermined period of time, the appropriateness information displayed on the display unit is set to a different appropriate Change to sex information,
The medical support system according to any one of claims 14 to 17.
The medical device is a drug injection device.
The medical support system according to any one of claims 14 to 18.
The medical device is a drug injection device for administering growth hormone,
The display unit of the communication device displays a bedtime input key for inputting the bedtime of the user.
The medical support system according to claim 19.
The communication device further includes:
An input unit controlled by the first control unit and operated by a user; and a communication unit controlled by the first control unit and communicating with other devices;
The first control unit acquires the usage information via the input unit or the communication unit.
The medical support system according to any one of claims 14 to 20.
The communication device further includes:
A first communication unit that communicates with the medical device;
A second communication unit that communicates with the server;
The medical support system according to claim 14, comprising:
The use information is at least one of presence / absence of drug injection, drug dose, drug administration time, temperature data and illuminance data of the medical device,
The medical support system according to any one of claims 14 to 22.
The first control unit or the second control unit is
Determining the appropriateness of the use state of the medical device based on the time between at least one of the user's bedtime, wake-up time, meal time and the administration time of the drug;
The medical support system according to any one of claims 14 to 23.
The first control unit acquires user life information including at least one of a user's wake-up time, meal time, sleep time, exercise amount, meal amount, exercise start time, and exercise duration time,
The first control unit or the second control unit determines the appropriateness of the user life based on the user life information,
The appropriateness information is generated based on the determined appropriateness of the user life and the appropriateness of the use state of the medical device, and is displayed on the display unit.
The medical support system according to any one of claims 14 to 24.
The first controller is
Get physical condition information indicating the level of the user's physical condition,
The first control unit or the second control unit changes a determination level of appropriateness of the use state according to the physical condition information.
The medical support system according to any one of claims 14 to 25.
The usage information includes the dose of the drug,
The first control unit or the second control unit determines the appropriateness of the use state of the medical device based on a comparison between the set dose of the drug and the dose of the drug included in the use information. To
The medical support system according to any one of claims 14 to 26.
Get medical device usage information,
Recording usage information of the medical device in a memory;
Determining the appropriateness of the use state of the medical device based on the use information;
Appropriate information indicating the appropriateness level of the use state is displayed on the display unit,
When it is determined that the use state is appropriate, the appropriateness information displayed on the display unit is updated to the appropriateness information whose level of appropriateness has been increased.
Medical support device.
A medical support method using a communication device capable of communicating with a medical device and acquiring use information of the medical device,
Recording usage information of the medical device in a memory;
Determining the appropriateness of the use state of the medical device based on the use information;
Appropriate information indicating the appropriateness level of the use state is displayed on the display unit,
When it is determined that the use state is appropriate, the appropriateness information displayed on the display unit is updated to the appropriateness information whose level of appropriateness has been increased.
Medical support method.
A medical support program for causing a computer to execute a medical support method using a communication device capable of communicating with a medical device and acquiring usage information of the medical device,
Recording usage information of the medical device in a memory;
Determining the appropriateness of the use state of the medical device based on the use information;
Appropriate information indicating the appropriateness level of the use state is displayed on the display unit,
When it is determined that the use state is appropriate, the appropriateness information displayed on the display unit is updated to the appropriateness information whose level of appropriateness has been increased.
Medical support program.